Nature of postheparin plasma clearing factor by Baskys, Bronius
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Dissertations and Theses (pre-1964)
1959
Nature of postheparin plasma
clearing factor
https://hdl.handle.net/2144/22327
Boston University
BOS'IDN Ut.'IVERSIIT 
GRADUATE SCHOOL 
Dissertation 
NATURE OF POSTH~ARIN PLASMA CLEARING FACTOR 
by 
Bronius Baskys 
(A.M., Boston University, 195 5) 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy 
1959 
ii 
Approved by 
Firat Reader \1?t tic . e . \~ ()--.\ 
Professor ~:r.unochemistry~ 
Second Reader 
Professor In Dermatology 
iii 
A.CKNoo.EDGEMEN'l'S 
I wish to express rq sincere thanks to Professor Willilllll c. Boyd 
and to Professor Walter F. Lever. Without their help and cooperation 
this wrk could not have been possible. 
M;r sincere thanks go to Dr. Edaund Klein and to Dr. Laszlo L. Fekete 
for their interest in my work and their valuable advice. 
I also wish to thank all the -bers of the Department of Dermatology 
of the Harvard Medical School for their cooperation with me in this work. 
iv 
TABLE£! CONTI!m'S 
Page 
lntrodnction •••••••••••••••••••••••••••••••••••••••••••••••••••••••• l 
Review of the Literature •••••••••••••••••••••••••••••••••••••••••••• 4 
Experilllen tal 
Materials and methods •••••••••••••••••••••••••••••••••••••••••••• 17 
Optical density method •••••••••••••••••••••••••••••••••••••••• 17 
Gordon 1 s method !or the detel'llinatian ot fatty acids •••••••••• 18 
Glycerol dete~ination .. tbod ••••••••••••••••••••••••••••••••• 20 
Separation o! clearing factor •••••••••••••••••••••••••••••••••••• 21 
Low taaperature ethanol fractionation ••••••••••••••••••••••••• 21 
B7 extraction with ether •••••••••••••··••••••••••••••••••••••• 26 
Purification of clearing factor •••••••••••••••••••••••··········· 31 
By ammonium sulfate ••••••••·•••••••••••••••••••••••••••••••••• 31 
By adsorption on calcium-phosphate gel •••••••••••••••••••••••• 33 
B,y changing pH •••••••••••••••••••••••••••••••••••••••••••••••• 37 
Isolation an!l purification of clearing !actor by rspeated 
extractions with ethyl ether ••••••••••••••••••••••• 39 
Flow sheet •••••••••••••••••••••••••••••••••••••••••••••••••••• 41 
Description of isolated clearing tactor •••••••••••••••••••••••••• 46 
Free boundar,y electrophoresis ••••••••••••••••••••••••••••••••• 46 
Ultracentrifugation ••••••••••••••••••••••••••••••••••••••••••• 48 
Stabilit7 ••••••••••••••••••••••••••••••••••••••••••••••••••••• 49 
Chemical composition •••••••••••••••••••••••••••••••••••••••••• 51 
v 
Kinetic studies or the clearing factor ••••••••••••••••••••••••••• 52 
Effect of temperature ••••••••••••••••••••••••••••••••••••••••• 52 
Etfect of hydrogen ion concentration •••••••••••••••••••••••••• 
Effect ot enzy.me concentration •••••••••••••••••••••••••••••••• 52 
Effect or substrate concentration ••••••••••••••••••••••••••••• 53 
Substrate specifici~ for clearing factor reactions •••••••••••••• 63 
Standard tat anulaian ••••••••••••••••••••••••••••••••••••••••• 63 
Triacetin ••••••••••••••••••••••••••••••••••••••••••••••••••••• 63 
Cbyiamicrons •••••••••••••••••••••••••••••••••••••••••••••••••• 64 
Beta lipoproteins • •••••••••••••.•••••••••••••••••••••••••••••• • 64 
Effect of protein and calcium •••••••••••••••••••••••••••••••••••• 67 
Rate at which triglycerides are hydrolyzed ••••••••••••••••••••••• 68 
Comparison of lipolytic action of pancreatic lipase and 
clearing factor ••••••••••••••••••••••••••••••••• 72 
SUbstrate specificity •••••••••••••••••••••••••••••••••••••••••••• 72 
Effect of protamine and serum proteins ••••••••••••••••••••••••••• 74 
Results and Discussion •••••••••••••••••••••••••••••••••••••••••••••• 76 
Purification o! Clearing factor •••••••••••••••••••••••••••••••••• 76 
Physical-chemical oharactaristics of purified clearing !actor 
preparation ••••••••••••••••••••••••••••••••••••• 78 
Kinetic studies on purified clearing factor •••••••••••••••••••••• 80 
Summar.y and Conclusions ••••••••••••••••••••••••••••••••••••••••••••• 84 
Bibliograpb7 •••••••••••••••••••••••••••••••••••••••••••••••••••••••• 87 
vi 
TABLES AND FIGURES 
Table No. Page 
r. Lipolytic activity of postheparin plasma .fractions 25 
obtained. by ethllllol .fractionation. 
II. Lipolytic activity o.f postheparin Plasma .fractions 30 
obtained. by ethyl ether extraction •thod.. 
III. Lipolytic activity of .fractions obtained. by ammoniUJII 32 
IIUJ..fate precipitation o.f crude clearing .factor. 
IV. Lipolytic activity present in the eluates obtained. after 36 
washing c.f calcium phosphate gel with adsorbed. cleariDg 
.factor. 
v. Lipemia clearing activity of the .fractions obtained. by 38 
increasing hyd.rogen ion concentration in a crude clearing 
.factor preparation. 
VI. Lipolytic activity present in the postheparin plasma 44 
.fractions af't.er ether extractions. 
VII. Isolation 111d pnri:fication o.f clearing .factor by extraction 45 
.from postheparin humm plaama with ethyl ether. 
VIII. Effects of temperature and protein on the stability of 
clearing .factor solutions. 
II. Effects of tiiRperature on reaction velocity o.f clearing 
.factor. 
x. The et.rect o.f hyd.rogen ion concentration on the reaction 56 
velocity o.f clearing .factor. 
XI. Effect o.f clearing .factor concmtration on the vebcity 58 
o.f lipolytic reaction. 
XII. Effect o.f substrate concentration on clearing .factor 60 
activity. 
XIII. Effect o.f substrate concentration on clear.i.ng .factor 61 
activity. 
XIV. Lipolytic activity o.f clearing .factor in the presence c.f 66 
different sUbstrates. 
xv. calcium ion and alblllllin influence on the lipolytic action 67 
o.f clearing .factor. 
XVI. The rate of trigly'ceride hydrolysis in the presence 
of clearing factor. 
vii 
69 
XVII. Ccapariaan of lipolytic action of clearing factor and 73 
pancreatic lipase on varioua substrates. 
IVni. The effect of protamine and sel'UIII proteins on the lipolytic 75 
action of pancreatic lipase and clearing factor. 
Figure 
1. Electrophoretic pattem of purified clearing factor 47 
preparation. 
2. Ultracentrif'ugal patterns of purified clearing factor 48 
preparation. 
3. Arrhenius plots for the actintion tEIIIperature of clearing 55. 
factor. 
4. The effect of hydrogen ion concentration on the reaction 57. 
velocity of clearing factor. 
5. Effect of clearing factor concentration on the velocity of 59. 
the lipolytic reaction. 
6. Effect of substrate concentration on clearing factor 620 
activity. 
7. The rate oft rigly'ceride bydrolysie in the preeence of 70. 
clearing factor. 
B. The rate of triglyceride hydrolysis in the presence of 71. 
clearing factor. 
illustration 
Semi-solid layer between aqaeous and ether phases after 86. 
centrifugation of plasraa-ether mixture. 
Illi'RODUC'l'IOII 
'l'he lipids or biological s;rat.s are cc.bil'led with proteins. 
A group ot lipid-protein 0011plex• C«lt•i a1ng Yary.lng aounta ot 
cllolestc-ol, phoapholipidll and 1l81ltr.J. tat in c011b:lnation viti!!. pro-
teirla • are ret erred to u lipoproteins. Depmding on the lipid- pro-
tein ratio the lipilprot.eirls Ytay irl specific dcsit;r. 
l. 
When nfttral. tat. is absorbed !rca the intestinal tract. it com-
bines with aaal.l. aount.s ot phospholipids, cholut.arol end protein to 
tom chTlOIIicra 'llhich aq be conaiciered u a particular clue ot low-
density lipoproteins. lllylOIIicra are present irl the lyJiph aDd blood 
u separate particles appl'IIIXillatel.T O.S - 1.0 llicron in diaeter and 
contairl· tro111 90 - 98 per cent or aore ot neutzoal tat. 
Becaue of thair large sise, c:bTllllicra scatter light and there-
tore when t.he;r are present irl higb concentration the plaaa appears 
llilk;r. After a tatty aeal. the concentration of chTlOIIicra irl the plaaa 
begins to rise, reachea ita lU:lda1a att.er a !fJtl hours, and then slowly 
falls to no:naal. l8Y8l.a. All the ch;TlOIIicron concentration decreases, 
the pla1111a bec0111ea aore traasparant. i'he phen0111enon of c:bTlClldcron 
disappearance hu bean oalled lipeaia clearing. All the concentration 
ot ch;TlOIIIicra decreases during lipeaia clearirlg, a coneOIIIitant irlcrease 
in the concmtration of lipoproteirl aoleculja of higher apecitic densi-
ties takes place. 'l'lulae obHrYations 81lggeat a lipid transport. raechanisa 
in which lipids first 1ppear irl the J.711ph and blood as large particles, 
are gradual 17 tr&aterred iato aaller and denser lipoproteirl Mlaculea 
and than leaft the blood atrea to be metabolized or stored.. It ia 
not known to which extent the intr&TUcular trana!ol"'ll&tion of' lov-
danllit;y lipoprotein• to higb-dansity lipoproteins ia a prerequisite 
tor tbe tranater of' tate f'r<a the blood to the tienes or tor their 
mov•ant in the reverse direction. 
Habn (46) in 1943, obeerYecl that intral'lllloue adllinistration of' 
heparin to li.pnic doge increaaea the rate ot lipemia clearing. Since 
addition of' heparin to lipmc ple•a ~ Yitro bad no ettect on the cCil-
oentration of' cby1a.iora, it vae concluded that after heparin administra-
tion a particular factor (later -4, "clearing factor"} is prodneed. 
'l'bere are reports eaggeeting that. clearing factor ie present in normal 
hWIIAID blood and is actbated when, alter a tatt7 meal, the neutral tat 
reaches the blood strea. 
It baa been shown that. clearing .factor acts on the t~erides 
or ct~Tla.icra lll&inlT b7 l~ia, i.e., by b;ydrol.Jsing the trialTcerides 
into tatty acide and glycerol. Very litt.le is known as ;yet about. the 
nature or the lipol7tl.c activity ot clearing factor. Some or the dews 
as to the nature or the lipo~ic activit;y of' clearing factor are listed 
below: 
(a} al.earing factor ia a distinctive lipaee containing heparin 
or another negativelT charged IIUcopol.JSaccbaride in ita structure (l~}. 
(b) al.earing factor is a beparin-pboepholipid caa:plu: and dia-
plep its lipo~io actidty by activating blood estaraeea and these in 
t11l'll b;ydrol.yse cbTla.icra preaant in the blood (1, 79}. 
(c) al.earing .factor 1a i4entical with the lipoprotein lipase 
(63, 6S). L~oprotein lipaee is a &J111l8 f'ound in 1118Dlalian tissues 
which b;rdrol.Jsea the neutral tat or lipoproteins to tree tatty acids 
2. 
and 817oerides or glJcerol. 
In this work it ball been atte.pted to isolate the clearmg 
factor an4 to atud;y its nature md kinetics. Since 1111t1l recentl.7 
clearmg factor could be obtained anlT 1n very crude preparations, 
the u1n objective of this work ball been to develop a 1118thod for 
purifTing clearing factor fraa the blood of humans to 1ihoa heparm 
* had been act.iniatered. The kinetic properties and l1pol7tic action 
of purified clearmg factor haw also bem investigated and compared 
with those of }MIIlcreatic J.ipaae. 
* hereafter celled llpoat-heparin blood." 
3. 
h. 
REVIEW OF THE LITERATURE 
Pbpico-ebemical. properties ot lipoproteinst At the beginning 
ot this cantury, Herting (93) and later HUlUI (47) suggested that the 
lipida present. in boq fiuids are usoci.ated with proteins and not noat-
ing in a tree state. In 1929, Macheboeut (85) first isolated a lipopro-
tein aoiet7 troa horse pl ... , which in addition to the protein COiltained 
18 per cct cholesterol and 23 per oct phospholipids. !n 19h6, Cohn 
and collaboraton (17) obtained aore co.plete plasma lipoprotein coa-
plexes by introducing a low-taperature ethanol-fractionation method. 
By thia aethod in which the h1Qrogc ion concentration, ethanol conoan-
tration, ionic streneth, protein concentration and. taaperature are con-
trolled, the CCIIIIpO!lenta ot blood plaaa are precipitated into several 
diatinctiw tractions. St~g the phT&ico-chtlllical. properties ot 
lipoproteins thus obtained Cohn at al. (17), <hcl07, Gurd, and Melin 
--
(101) and tncl871 Scatchard, and Bro1111 (102) found that the lipopro-
teins were almost exclusively preset in pla811& tracticns IV-1 and m-o. 
Since these tractiens lligrat.M electrephoreticall7 with the speed ot 
alpha-1-gl.obu.l.in 111d bete-l-globulin, respectively, they were named 
alpha arui beta lipoproteins. Beta lipoproteins (molecular weight, 
1,3001 000) were found to oonsiat ott 'Qileeteritied cholesterol, 8.4 per 
cent.; cholesterol ester, 22.5 per cent; phospholipid, 29.3 per cent; 
and protein 23.0 per cent. The chmcal. c011p0sition ot alpha lipopro-
teins (molecular weight, 200,000) wu found to bet protein, 61 per cmt; 
phospholipids, 2h per est; 111d choleeterol, l2 per cent. These tigurea 
5. 
are in good agreement with those giYc by other liDrkers tor tbe coa-
poeition ot lipoprotein coaplexes (107, 71, ll2, 48). The literature 
011 the lipoproteins in haan p~ has b- aore coap1e~ IIUIIIII8l'ised 
by <hcl.ey (99,98) and <holey and (lard. (100). 
Ultracctritugal. an&17sis ot the lipoproteins ot the blooda !be 
introcblction ot the ultraC«ltritage by S'f'edberg (119) opened a new ap-
proach to the study ot the lipoproteins present in blood pl&slll&. Besides 
its succesatul ~~pplication in the innatigaticn ot tbe aolecular ctlmen-
sions ot proteins (89, 106) the ultracctrituge has proved itselt Yer'f 
use.f\11 tor isolation ot lipoproteins. 
Gotman, Lindgren and Elliott (.36), increasing the density ot 
serua by the addition ot Nat:l. and applying high-speed centritugaticn, 
noated serua beta lipoproteins to the top ot the aixture. This aethod 
(82, 33) permits tbe isolation ot blood pl.&llma lipoproteins ot the specif-
ic density desired s:laply by varying the type and &11011llt ot salt added 
to the plasaa 1IJlder inYestigation. 
Using the SYedberg 1111it (St 1 x lo-13. f111/sec/dple/p) to aeasure 
the rate ot notation ot lipoprotein aolecules in a octri.tupl. field, 
Gotun!! !!• (34) and others (58) tOIIDCl beta lipoproteins to consist ot 
~Y classes at aolea~.les rmging tl'OII large, less dense aolecules ot 
S.r 40,000 to those ot higb density with St Yalues ot 4. Analysing Sel"QIIl 
lipoproteins by chellical. and !lltracctr:lhgal procedures, Gotman (32) 
and Gotmm and collaborators (35, .36) t01111d that the lipid portion ot 
sertlll beta lipoproteins aboYe St 17 consists ot cholesterol, phospho• 
lipids and neutral tat, while the lipid portion of high densit7 beta 
lipoproteins (St 4-17) contsins C11117 cholesterol and phospholipids. 
6. 
1b.ese authors also observed that with decreasing density the neutral 
fat content of lipoproteins increases. Jones and collaborators (58), 
stu<lying lipoproteins of human sera by ultracentrifugal and tracer 
techniques, concluded that the lifetime of low-density protein is in 
a range of several hours. On the basis of this finding and the quant-
itative studies of lipoprotein Sf classes in the ultracentrifuge, they 
suggested that the lipoprotein components with high Sf values are 
progressively transformed into those of the lower sf classes. 
Chylomicrons: - The milky appearance of blood plasma after 
fatty meals has been recognized for many years. In 1924, Gage and Fish 
(28), using dark field microscopy, observed the presence in the blood 
stream of fatty particles 0.5 - 1.0 u in diameter. These they named 
chylomicrons. They also observed that the cOl-centration of chylomicrons 
in the serum increased after ingestion of fat and became maximal 
approximately 2 to 3 hours after a fatty meal. 
Fraser and Stewart (25) and Cunningham and Peters (19) found the 
chylomicrons to consist almost entirely of neutral fat. Fraser (23), 
studying fat absorption and metabolism, concluded that neutral fat, 
after being absorbed into the lymph and the olood, is present as 
finely dispersed particles which carry a thin film of protein on 
their surface. Later, Fraser (24) reported that the physico-chemical 
properties of the chylomicrons found in lymph differ from those of 
the chylomicrons found in blood, an observation wr~ch suggests re-
distribution of neutral fat on the «ay from the lymphatic system to 
the olood stream. Havel and Fredrickson (49) found that half 
li!e of pal.llitic acid-l•cl4 - labeled chylcaicra in dog to be 15 to 
20 llinu.tes. 
7. 
Althou~ ch7lCIIIicrona conaiat (90 to 98%) of neutral fat and 
contain only lllllall aaounta of cholesterol, phospholipid and pro"in 
(22,23,2h) n~ertheleaa, th8J' are lipid-protein cc.pl.exea, and ae such 
are to be considered low danait7 lipoproteins. '!'he altracentrUugal 
studies reveal that the sf claases of lipoprotein& llhich have natation 
rates higber thanrsf boo actull7 represent Ch71CIIIicrons. Stu~g N-
terainal groupa ad electrophoretic lligrati<m of proteins associated with 
dog and h1111an obTlomicrons, Rodbell and Fredrickson (111) concluded that 
at leaat three t7Pea of proteins are associated vi th these cbylcaicrona. 
Heparin-induced clearing factor: - Ill 1943, Hahn (46) using hep-
arin as m anticoagulant in his studies on the ciroulati.ng II&IS of red 
cells in dogs, first observed the liptaia-clearing action of heparin. 
He noticed that. the lipemia o£ those dogs llhich received intravenous 
heparin, disappears at a au.ch faster rate than the lipemia of dogs llhich 
had not received heparin. It heparin 1f&l added.!!!,~ to lipemi.c 
pl&lllll& or serlllll, lipemia clearing did not take place. 
Weld (2h) in 1941! reported that the intravenous &lkiniltration of 
heparin causes clustering and disappearmce o£ c~lomicrons. Anderson 
and Fawcett (l) found that lipelllia clearing continued ~ vitro whan 
plasma or serlllll vas collected a ffN ainutea after intravenous adllinis-
tration o£ heparin to lipemic dogs. Ill addition to the clearing o£ 
lipaaic s81'1111, they fOWld that adldnistration o£ heparin lowered the 
nr:tace tension o£ the plaau.. On the basis of these findings, they 
8. 
postulated that !! !.!!!?, heparin 11&7 COIIbine vi th a phospholipid and thus 
produce a lipemia-clearing •antio~laaicrooemic £actor." In 1952, Au£in-
sen Boyle and Brown (2), employing a ooabination of: Cobft 1 s methods VI and 
n o£ low-temperature ethanol £ractionatica o£ post-heparin plaf.lll&, achieved 
£our-£old purification of: the lipemia-clearing coapcaent which they n-d 
"clearing £actor.• They also reported that the supernatant o£ tissue 
llinoed with heparin and hUIIIIIIl plaau. produces clearing o£ an added £at 
aaulsion. Hilcld.la and Pesola (96} in 1956 obtained £orty-£old pvUica-
tion of: post-heparin clearing £actor by increasing the ~gen ion con-
centration o£ post-heparin plaau. to pH 5.6, adsorbing the resultant pre-
cipitate on calciiDR phosphate pl and eluting it again with sodiua citrate. 
Recent:l71 Hollett md Meng (52) reported up to 1,480 tillles purit1cation o£ 
clearing £actor by £ractionating post-heparin pla8111& with -oni1111 suUate. 
The present author, howeTer, £ollowing their procedures, has been mable 
to purif'y clearing £actor by this •thod. 
Hood~ !!:• (55), Meng, Hollett and Cole (91) and Grossun (41) 
studieli conditions mder which the lipaaia clearing is optimal. They all 
agreed that the greatest concentration o£ clearing £actor is £ound in post-
heparin plasma 30 - 60 llinutes a£ter the intravenous administration o£ hep-
arin. Meng and collaborators reported that the opt:lJul. rate 11£ clearing 
£actor actirlty occurs at pH 6.4 - 1.0 and within the temperature range o£ 
35 - 400 c. Grosl!llll&n (41) on the other hand, £olllld the optilul. tem:pera-
ture to be 25° c. He £omd the clearing £actor to be Tery tberaolabUe, 
so that &£tar incubation £or one hour at 4o° C. it was c0111plet~ inactb'-
ated. 
Brown, Bo7le md Antin- (12) attacked the problem ot the aech-
miaa ot clearing tactor actbity. They postulated the occurrence ot a 
two-stage reaction aechmiam: 
9. 
Firat: plasma precursor prctein + heparin + tissue tactor ~ clear:ln.g tactor 
Second: low density beta lipoproteins + pluaa co-proteins clearing tactor ). 
~MaUer high densiv beta lipoproteins + alpha lipoproteins. 
Kunkel and Bearn (66) adainist.ered P32 labeled phospholipids to 
hlDil8Zl s'llbjects &Rd. tound. the radioactivity dist.ributed Mong alpha and 
beta lipoprcteins. They also d•onstrated exchanges of phoephatides talc-
ing place between lllpha md beta lipoproteins. I!Dploying OJ..h and S3) 
labeling, Golll.d (39) tound that choleet.erol can. aleo interchange between 
alpha and beta lipoproteins. Supported by the tindings ot their electro-
phoretic studies on plasma lipoproteins atter t.he atfmini st.ration ot hep-
arin, Herbst., Lever, Lyons and Hwley ()1) criticized the reports on the 
convereion ot beta l~roteins into alpha lipoprcteins dnring lipaaia 
clearing. Gitlin _!! _!! (31) studied the interconvers:!Dn and turnover 
ot peptides connected with lipoproteins ot var;ying densities. Peptide 
aoiet.ies ot lipoprotein wre labeled with !131 and tracer doses were in-
jected to no:nul. individuals and to children with nephrotic &7Jldrome. On 
isolation ot alpha and beta lipoprotein aoleculee of various di:llensions, 
no int.erohrmge ot peptide aoieties between alpha and beta lipoproteins 
was found. The tindings of Avigc, Redfield and steinberg (3) that lll.pha 
and beta serum lipoproteins have ditterent N-tel'lrlnal residues supports 
the view that there is no interoonversion between alpha and beta lipopro-
teins. 
lO. 
Shore, Nichols and Fr-1111 (ll7) md Nichols, Rubin md Lindgren 
(94), alter incubating post-heparin pla•a or "heparin active factor" 
with lipoproteins obtained tr0111 egg 701k, found partial hydrol.7sil ot 
t&e ~ceride c•ponmt ot the lipoproteins, suggesting a lipolytic action 
ot the clearing factor. 
Levy and Swank (79) found increased act.ivity ot blood ell'terases 
atter the adllinistration ot heparin. Tbe;r suggested that increased ester-
ase activity aq be responsible tor the lipolytic activity obaerYed attar 
ainill'tration ot heparin. 
Overbeck and Van der Vies (lo4), stud;ying the effects ot variQI.s 
substancee kncnm to inhibit and accelerate the action ot pancreatic lipase, 
alli-eeterases (lOB) and clearing factor, concluded that clearing factor 
is not identical with alli•esteraees or pancreatic lipase. The lipolytic 
activity ot clearing factor nov is well established and bas been con-
tiraed by amy investigators (l2, 43, 6.3, 109). 
French, Robinson and Florey (27) have reported thll't the addition 
ot noraal pl881118 to a llixt111'8 ot poat-beparia pla- and ch7le increaees 
the rate ot ch7l.e clearing. fhey suggeated that a plaaa factor other 
than heparin mq detera:l.ne the rate ot the clearing reaction. Gordon 
!! !!.• (38), using post-heparin plaaa active traction md coconut oil 
aaulsicm as substrate, tcilmd that the addition ot alblDin (bovine or 
hwun) increases the rate ot clearing or the lipellic llixture. They also 
found that the addition ot 0.005 Ill ot nol'll&l. serum to the mixture of 
their clearing factor preparatian md coconut oil increases tbe rate ot 
the clearing reactian by 50 per cmt. On the basis ot these t:l.ndinga 
the authors poll'tulated that a pla811UL co-factor is necessary tor the 
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lipemia clearing reaction. 'l'he iJiportance ot alblllllin in lipemia clear-
ing has been stressed by lf11dd.le (~), GrosBIUll et al. (44) and others 
--
(US, 26). !:orn (63) has reported that the role at albuldn in the clear-
ing reaction ill to accept tree tatty acida and that albwrln can be re-
placed by other tree tatt;r-Uid acceptors u, !or example, calcima ion. 
Selden and Westphal (116) • npporting the idea that serum albmain acts 
u a tree tatty-acid acceptor, have suggested that the te:rm "nonesteri-
tied tatty acids (HErA)" be uMd instead ot •tree tatty acids" since 
serum tatty acide are bomd to the albain and therefore not tree. 
Levy and Snnk (78) cd later Worley and Lequire (12S) round 
lipaia clearing to be accelerated in tat-ted dogs when the dogs were 
put in peptone or anaphylactic shock. 'l'hese authors suspected that the 
ralease ot heparin vas respcmsible tor the observed liperda clearing. 
Injecting 20 -So Ill. ot cottonseed oil ..W.sion or merely the emuls1t;y1ng 
agentl without tat to tuting dogs, Lever and Baalcys (70) observe4 that 
clottina time cd lip.U. clearing activity were prolonged in the collect-
ed plasma ot these dogs. Since these chcges were reversed by the sub-
sequent adRinistration ot protamine, they concluded that the admfnfstra-
tion ot phosphatide preparation to the dogs stimlllated the release ot 
heparin or a heparin-like uterial. Brown (11), Gilman, Hathorn and 
Penn (30) and others (18) have found that dextran sulfate and 1101118 other 
sulfated pol;ysaccharides have a heparin-like lipaaia-clearing ettect when 
adllinistered intravenously. 
1. :&luls1t;y1ng agent wu 1.2 per cent so;pbec phosphatide; 4.2 per cent 
dextrose. 
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Lipoprotein lipan Yerfta clearilig taetors - Incubating aoun 
P7loru extract with heparin Brown and J:auflaan (13) to\11ld that prc4uction 
ot cleariag factor is alae taking place ~ Titro. 
Xom (63, 62) enracted troa acetone-dried heart and adipose tili-
ne powder a lipolytic ageat which he n-d lipoprotein lipase md iden-
tified it u baha'rlng like po8thaparin clearing taetor. He auggeeted. 
that lipoprotein lipue is a natin lipolytic enzyme ot blood and tillsuea 
which hydrolyzes the triclTceride aoietiea ot alpha u well u beta lipo• 
protein aolecules to tree tatty acid and glycerol. 'l'he following onrall 
reaction wu proposed. by Kom u taking place: 
1. Alpha lipoproteins + tricl7ceri4es non anzl!l&tical.ly ) chylomicrons 
2. (hylCIIIIiel'ODII lipoprotein lipase ) tatty acids + glycerol + 
alpha lipoprotein 
Overbeck (103) in s111111.arising the tat h7drol;ysing enzyaes ot the 
blood nggeats that clearing factor is a aillple lipase containing hep-
ar:i.R or another negatiTel.y char&ed llllcopolyaaccharide in ita atmctura. 
When heparin ot poatheparin pla- wu removed ea m ion axchqa resin, 
Robinson (109) .f'0111lcl that the etfi'Ull~ still had lipolytic actiTity but 
wu lass stable. Addition ot aal.l. aao\11lta ot heparin restored the sta-
bility to the leT8l ot the starting -terisl. Kom (64) found 6o per cent 
inactbation of ita lipoprotein lipase preparation when incubated with 
heparin-11etabolbing bacteria (105). He interpretecl this as evidence that 
heparin is an essantilll. component ot lipoprotein lipue. 
Action of protadne and other inhibitors on clearing factor: - Froa 
the work of Chargaff' and Olson (15) and others (123) it has been known 
that protamine has an antagonistic ettect on heparin in respect to blood 
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coagulation. Brown (ll) in 1952, stud;)'ing the mutual effects of heparin 
and protamine on al:illlentary hyperlipemia, found that protamine antagonized 
heparin also in regard to lipemia clearing. Under the ac:tion of heparin, 
the disappearance of lipemia is reversed within a few minutes after ad• 
llinist.ration of protamine. Spitzer (ll8) reported that lipemic dogs be-
came aore lipemic on administration of protamine. Bragdon and Hovel (10), 
st~g substances which fora insoluble COIIpOunda with heparin, found 
that only protamine reTerses the ef'f'ect of' h~arin on alimentary lipemia 
in non-toxic doses. The inhibitor:r and reversing action of' protamine on 
liplllllia clearing has been well substantiated b7 IIAliT other investigators 
(45, 73, S4, 55). 
Stu~ al.illlentar:r lip8111ia clearing after heparin administration 
to 100 subjects with coronar:r diseases and 100 control subjects, Oliver 
and Boyd (97) found that aliaent;aey lipllllda clearing rate increased onl:r 
in 50 of' the individuals w:l.th OOl'Gil&r:r disease, whereas it increased in 
all the control subjects. Hollett and Meng (53), Lever and Klein(74) 
and Klein, Lever and Fekete (60) have reported the presence of' specific 
clearing factor inhibitors in lnutan and anilllal blood and tissues. 
li'f'ect of' clearing factor on 11J!!I!!ia clearing and on the lipo-
proteins of' the blood: - In 1951, Gr8ham and collaborators (40) obsened 
the redistributing action of' heparin on the lipoproteins. They reporteds 
"Heparin administered to h'llllans and rabbits causes profound re-
orientation of' the distribution or law density lipoproteins 
ohar.acterized by a shitt of lipoproteins ot high Sf rates to 
those ot successively lower Sf rates. The association of these 
two changes suggesta a progreaaive conversion of' the higher St 
lipoproteins into those of lower Sr rates." 
l.h. 
Loewe ~ .!!• (8h) stu!Ving the et.f'ect of heparin on the serum lipoproteiJ:I.s 
o.f' nonul subjects, and later Lever, Herbst and Lyons (72) studying the 
e.f'.f'ect o.f' heparin on the serum lipoproteins o.f' patients with idiopathic 
hyperlipemia and pl'illary hypercholestereaic xanth011B.tosis1 con.f'irm.ed the 
previous reports that the adlllinistration o.f' heparin causes a shi.f't o.f' 
lipoproteins .f'ro111 the higher to the lower S:r classes. Lindgren, Freeman 
and Grah• (81) reported that lipoprotein trane.f'ormation also takes place 
~ vitro. These authors incubated the •active traction" o.f' post-hepariJ:I. 
pl8.8111a (obtained in the bott011 of the centrifuge tube attar high epeed 
centrifugation) with lipoproteins o:f the St 20 - 200 class and obtained 
lipoproteins o.f' the S.f' h - 20 cla1111 e.f'ter 60 minutes o:f incubatiClll. Boyle, 
Bragdon and Brown (9) reported that the conversion o.f' alpha lipoproteins 
o.f' low density to alpha lipoproteins o.f' higher density takes place ~ vitro 
in post-heparin h•an plaSBla. Carlson and WadstrGIII (lh) suggeSted that when 
the triglyceride traction o.f' the lipoprotein aolecule ill hydrolyzed to 
.f'atty acids and glycerol, the lipoprotein is automaticel.l.7 trans.f'omecl into 
denser aolecule. The findings o.f' Levine, Kau.f'man and Brown (77) that the 
protein portions o.f' low-ciebsity lipopMteins arejmtigmical.ly s:ilrdler 
seem to support such th1n!dng. Employing .f'ree-b01Dlclar,y and paper electro-
phoresis aethode1 Lever, Slllith and Hurley (75) and Herbst, Lever and Hur-
ley (50) observecl that adlliniatration o.f' heparin to patients with idio-
pathic h7Perl1pemia and to subjects with alimentary hyperlipllllia increases 
the speed o.f' electrophoretic migration o.f' serum lipoproteins. They .f'ound 
that in all cases a.f'ter intravenotlll administration o.f' heparin the oonoen-
tration o.f' chTlom1crons decreases and that the beta and alpha lipoproteins 
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migrate at an increased rate. These authors suggested that the lipolytic 
action of clearing factor is responsible for the increased electrophoretic 
mobilities of eerum alpha and beta lipoproteins. Following is a direct 
quotation fr011 Herbst, Lever and Hurley (50)s 
"It seems more likely that products released by the action of the 
heparin-induced clearing factor cause the electrophoretic changes. 
If we assume that the increSie in electrophoretic mobility of the 
alpha and beta lipoproteins after an injection of heparin is due 
to the binding of fatty acids by these lipoproteins several find-
ings in our study would find an explanation." 
These euggestions were later substantiated by the observation (7) that 
incubation or pancreatic lipa8e with trigl.yoerides in the presence or 
nomal plasma or even ~ !:!!::!! addition of small amounts of oleic acid 
to normal plasma increases the electrophoretic mobility of serum lipo-
proteins. The findings of McDaniel and GrosSJIIan (88) also support the 
view that the lipolytic action of clearing factor causes the changes in 
electrophoretic migration of serum lipoproteins. 
PhYsiologic action of clearing factors - Engelberg (20) found 
endogenous clearing factor present in the untreated pl&8111& of 25 out of 39 
normal individuals tested, but he was unable to detect clearing factor 
activity in the serum of these same individuals. Gates and Gordon (29) 
found lipolytic activity in the serum of 7 human donors. They concluded 
that the weak lipolytic activity is due to the presence of lipoprotein 
lipase in the serum of these donors. Robinson !! .!!· (110) reported 
0 
that lipanic human plasma after a tatty meal, when incubated at 37 c., 
shows slight spontaneousblearing activ.!.ty. These findings have been 
confirmed by other investigators ( 7, 76 ) • The above reports 
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suggest that ol.earing factor is a phy'lliol.ogical. substance which comes into 
plq particularly attar absorption of tat. Lindgren snd collaborators (80), 
studying blood lipoprotein transtoraation, concluded that 
"the introduction of a tat load into the blood stre11111 in the fora 
ot cbTlalicra or lipcaicra probabl.J' is the initiating factor in 
lipoprotein transtomation. In s011e wq this tat load aast stim-
ulate the clearing factor uchani11111 possibly through heparin re-
lease. As the result of an increase in sel'WII lipoprotein lipase 
activity the lipoprotein trllllllforation reaction is driven through 
the entire Sr 20 - lo5 renge ot lipoprotein COIIPlexes. The actual 
transtoraat1.on ot high Sr lipoprotein CGIIIplexes to lower sr lipo-
protein caaplexes is achieved bT glyceride hydrol.J'Sis (at the 
surface of the cJ.Tceride core) with tatty acid release." 
Soxl (113, llh), stw:ll'ing the lipid utabolisDt ot aging uterial. 
tissues, reported a mec:b.snisa tor clearing factor production. She folDld 
that incubatiCID of elastase (4, 5, 6) with fresh l.ig811ent1DI nuchea or 
h1DIIIIl aorta tor 20 hours, releases tat globules into the butter. .&.ddition 
of' alJ!haJ. and al.~ tractiCIIls of s81"11111 globulin to that llixture resulted 
in rapid clearing of the solution. The disappe8l'ance of cbTlOIIicra dur-
ing that clearing reaction was deaonlltrated b7 the electron lllicroscope. 
The author conc:luded that elastase (in particular the mucolytic portion 
ot elastase) anci a aucopol.J'Uccharide c0111plex react with al.phal and 
alp~ tractions of' sertua globulin to fora clearing factor. 
This brief survey of the literature shows the illportance of the 
role of clearing factor in the aetabcli811 md trmaport of lipids. The 
present investigation has been 1Dldertaken in the hope that it aq con-
tribute to better 1Dlderstanding of the nature and aode ot action ot this 
lipolytic agent. 
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EIPBRIKillTAL 
I. SEPARA.TIOX AND COHCENTRATICII Cl' CLEARDTG FACTOR 
A. MATERIALS 
Polltheparin hU11181l plasm• vas used as starting aateriaJ.. cne 
ai 11 i gram of socii- heparin vas adldnistered intraTellously per kilo-
graa of boc:IT weight to nomal h1J91111 IIUbjeots, and 30 ainutes later 
blood vas collected into acid citrate dextrose solution. Plasma vas 
separated b;r centrifugation tor 30 ainutes at 2,000 g and store4 at 
SO c. Sterile precatione were uiDtained throughout these procedures. 
B. METHODS OF DITERKINDTG LIPEMIA ClEARING ACTIVITY OF POSTHEPARlN 
PLASMA AND ITS FR.A.CTIWS 
1. Groseaan•s method of aeasuring optl.eal dsnBity (41}. 
This lll!thod is e~~~ployad tor the purpose of screening and 
COB.paring various plallll&IJ and plalllll& tractions with clearing factor 
actirlty after addition of a fat eaulsion. 
(a) Principle 
Optical density- of a solution, in the limits of Beer's law, 
is directly- proportional to the concentration of light adsorbing or 
light scattering -terial present in that solution. When in these 
tests tat eaulsion is cleared by- the action of clearing factor (prob-
ably- due to the dl.seppesrance of ~lGIIIiorons) the optical density- of 
the amulsion decreases and is aeasured in a spectrophotllllleter. 
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(b) Procedure 
To 1.2 Ill of posthepa.rin plana or to the same WlUJle of the 
other eyst11111 0.3 Ill of standard fat emulsion, 2 diluted 1:30 with water, 
ia added and the optical clsnsit;r of the mixture ie IIBasured at nrious 
time intervals in a Colllllln J1111ior Spectrophotaaeter at 700 using 
distilled water as a blank. Between readings the samples are kept in 
the 37° c. water bath. 
The lipolytic action of clearing factor is measnred b7 detBl'Rlining 
the products of trigl;rceride IITdrol.Jais, namel;r unesterified fatt:r 
acide and gl;rcerol. 
2. Gorclon•s 118thod for the determination of fattz acids (37). 
(a) Principle 
In this Mthocl 1111asterified :tattz acids are extracted and 
titrated with dilute alkali o:t known normalit:r. 
(b) Procedure 
Froa 1 Ill to 2.S ml portions of the reaction mixture are 
quantitatively- placed into SO Ill screw-topped tubes and iBiediatel;r 
:trosen in an ethanol-dry ice bath. During freezing the tube is re-
volved on si.tt in the bath so that the frozen saaple covers lt• to 
2" up the side of the 'lllbe. The water from these samples is removed 
b;r vacuum-d.r;ring in a :trozat state far 4 or aore hOIU!s. To the dr1 
2. Standard fat 1111alsion was generousl.:r supplied b;r Dr. E.A.Hawk, 
Medical Division, Dept. of Clinical Investigation, The Upjobn Co., 
Z:alamazoo, Michigan. It consisted o:t: lS% coconut oil dil!persed 
as one aicron particles in water CGnta1ning O.S% Pluronic (a non-
ionic detergent) and 1.0% pol;rgl;rcerololeata. 
saaple 30 Ill or a 1:1 llixt.ure or acetic acid glad.al. II1Ci iec-octane 
(2,2,4-~etbTlpentllle) aolution is added, tile llixt.ure is gently 
shakm tor a tew seconds and lett standing for 30 minutes. At this 
tille the blank is prepared consisting ot 30 Ill of the acetic aciti-
iao-octane solution and also the st.nd.at"d consisting or l Ill or 
0,002 lf palmitic acid in iao-octane, 14 Ill ot iso-octane and lS Ill 
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ot glacial acetic acid. The tubes are centrifuged .for 2 minutes at 
S,OOO g and tNm each tube 2S Ill of the soluticn iB quantitatively 
transferred into another SO ml screw-topped tube, To the transferred 
solution 2S Ill or 1:2,000 dilute sulfuric acid are added and llhakm 
b;y invertinc the tube 10 timu. (The screw top or the tube must be 
provided with teplon lining in order to prevent leaking). The aix-
ture in the tubes is centri.f.'oged .for llllinute at 3,000 g and the 
intrsnatant. (acetic and sulturic acid aolution) is removed b;y aeans 
ot a long needle and s;yringe. The washing with dilute sulfuric acid 
ot the reaaining iso-octane and .fatty acid solution is repaat.ed twice, 
leaving the aixture after the last vashinc to stand overnight at S0 c. 
Again the phases are separated by centrifugation and the 
aqueous phase is reaoved b;y lll8ans of a s;yrince, S Ill ot triple-
washed enpemat.ent and l Ill ot Nile Blue indicate~ are quantitatively 
placed into lS al conical centrifuge tubes and 0,02 lf NaOH solution is 
obtained, The contents in the titration tube are mixed b;y bubbling of 
3. 1:9 stock aqueous solution or CC~~~Dercial Nile Blue A (0,02 per cent 
in water washed with iao-octane until tree or extractable colored :bl-
purities) and absolute ethanol. 
nitrogen gas, For the calculation of titratable acidity present in the 
sample under determination, the following equation is used: 
microequiv- ml 0.2 N N&OH 
alents of I for unknown -
standard titration 
ml 0.02 N N&OH 
for blank titra-
tion microequivalents 
--------------------- • of acid present in the sample 
ml 0.02 N N&OH Ml 0,02 N NaOH 
for standard - for blank titra-
titration tion 
3. Glycerol determination by the method of Lambert end Neish ( 68) 
(slightly modified) 
(a) Principle 
OXidation of glycerol by periodic acid to fonnaldehyde end 
coupling the latter w1 th chranotropic acid reagent 4 to gi w a colored 
solution. 
(b) Procedure 
FrOm 1 to 2.$ ml of reaction llixtures are quantitatively 
placed into SO llll test tubes end 9 ml of 2 .S per cent solution of tri-
chloracetic acid are added sm the mixture is centrifuged for 1$ minutes 
at S,ooo g. lO ml or the supernatant is quantitatively placed into 
100 llll volumetric nask end diluted to 20 ml with distilled water. The 
solution is acidified by the addition of 1.0 ml of 1 00 H2S04 and then 
is reacted with S ml of O.l M sodium periodate (Na3H2lo6) for exactly 
S minutes. After S minutes the oxidizing action of sodium periodate 
is stopped by the addition of S ml of 1.0 M solution of sodium arsenite 
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4. 1.0 g of chromotropic acid (1.8 dihydro:xynaphtalene - 3.6-disulphonic 
acid) is dissolved in 100 ml of distilled water and 400 ml of 12 N sul-
phuric are added. 
(NaAS02). After standing tor 10 ainutes, the CCIIltents in the volu-
aetric tlallk are diluted to 100 al aark with distilled water. 'fhen 
1.0 llll ot the soluticm is placed into a 25 ml pyrex test tuba and 
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10 Ill ot chromotropic acid reagent (86) added. The contents in the 
teat tubes are aixecl and placed in bolling water bath tor .30 minutes. 
To prevent direct light trcm falling on the tubes, the water bath is 
kept in a dark place. J.tter heating, the tubes are cooled to room 
teperatum by ranning cold water and the aolution is transferred in-
to 19 x 105 -· Colean cuvettes. The optical density readings are 
taken at 570 llillimicrona using distilled water as a blank. 
The standard glycerol cu.rve ill prepared (by determining 
optical densities ot knam CCIIlcentration ot pure glycerol in tasting 
plasu.) and the obtained optical density values are converted into 
llicrogrsms ot glycerol. 
C. PROCEDORES liMPLOlED FOR CIBARING FACTOR SEPARATICti 
1. FractionatiCID ot pc!8 theparin plasma !11flozing Cohn 1 a low temperature 
ethanol Ethod. X (16). 
Reports in the literature on clearing tactor activitT tound 
in the postheparin plalllll& tractiona atter low t.perature ethanol frac-
tionation suggested a prollising -thod tor obtaining crude clearing 
tactor preparation tor possible further purification. 
(a) Reagenta 
Reagent A 
250 ml 95 per cent ethanol 
2.4 ml acetate butter 
Dlluted to 1 liter b7 distilled water 
Acetate Butter 
20 Ill. 4 M aocliwn acetate 
40 llll. 10 N acetic acid 
DUuted to l liter with distilled water 
Reagent B 
17$ Ill 9$ per cent ethanol 
4S p glycine 
1.0 Ill l M aod111111 acetate 
1.0 ml l N aoetic acid 
DUuted to l liter with distilled water 
Reagent C 
160 Ill 9$ per cent ethanol 
4S ga g}¥cine 
2.$ Ill aodima glycinate butter 
3.2 Ill 0.$ Jf N~04 aolutian 
2.4 1111 o.S M NA2HPo4 solution 
Diluted to l liter with distilled water 
Sod11D11 Glycinate Buffer 
7$ p gl.)-c.l.ne 
20 ga Naal 
DissolYed in 1 liter of distilled water 
(b) Procedure 
100 Ill or postheparin pla•a and 400 ml of reagent A are 
precooled to 0° c. and lldxed in a 1,000 Ill Erll!llllleyer fiask. The 
lldxture is kept at -$0 c. tor 1$ ainutes in an alcohol-water bath 
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and ill continuously aixed by aeans at a mechanical stirrer. The 
formed precipitate (Fraction I + II + m) is separated by oentritu-
gation tor 30 ainutea at 8,000 g and -$0 c. S11111ples or Fractiona 
I + II + III and ot the supernatant containing Fract.ions IV + V + VI 
are taken tor the deteminat.ion at clllaring tactcr activiw. 
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'l'o the precipitate (containing Fractions I + II + III) l6o al 
ot reagmt B are added end the aixture is stirred tor one hour maintain-
ing the t•perature at -SO c. 'l'he resulted precipitate containing Frac-
tions I and m is separated. by O&ltrifugat.ion at 3,000 g and -SO c. 
tor 30 ainutes. '!'he saples ot the precipitate and or the supernatant 
conta:l ning Fraction II, are Ulllld tor the determination or clearing rae-
tor activit,-. 'l'o the rest or the precipitate containing Fractions I 
and III, 200 al or reagent C are added and the mixtnre is kept in an 
alcohol-water bath at -SO c. while stirring mechanically for one hour. 
'l'he mixture is cmtrUuged at 31 000 g and -SO c. for 45 ainutes and the 
presence or clearing factor act.in ty in the supernatant md precipitated 
fractions is detel'llline d. Attar ~oval. of ethanol by evaporation under 
vaculllll, the following ayat•a of the collected ••plea were prepared in 
dil.plicate and the lipeaia clearing acti011 tested. 
'l'o eaoh or the following tubes containing& 
(a) J,.OO ag. or wet weight Fractions I + II + m dissolved in 0.6 al 
phosphate buffer at pH 7.4 
(b) o.6 al of supernatant containing Fractions IV + V + VI 
(c) 0.6 al of aupernatmt containing Fractions IV + V + VI plus 
50 ag of wet weigllt Fractions I + II + III 
(d) 100 ag. of wet vei@ilt Fra.Uon I + III dissolved in o.6 ml 
phosphate buffer at pH 7.4 
(e) 0.6 ml supernatant containing Fraction II 
(f) 0.6 ml supernatant cmtaining Fraction II plus 100 ag. of 
wet weipt Fraction I + III 
(g) 100 ag. of wet weipt Fracticn I + m - 1, 2, 3 
(h) o.6 ml of supernatant containing Fraction III - 0 
(i) 0.6 ml of phosphate buffer at pH 7.4 
(j) o.6 ml poatheparin plasaa 
0.6 ml of noraal preheparin plaama llld 0.3 ml of standard !at 
.W.aion are added and the optical density and glycerol value 
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0 
are determined before and after inCilbation for 60 minutes at 37 c. 
The results of these detenninatione are reported in Table I. 
* Bxp. 
No. 
1. l'raotiODS 
I+II+III 
2. J'ractiODs 
D+V+VI 
'· 
l'raotiOI!l 
n 
4. Fractions 
I+m 
s. FractiODS 
ni-o 
'" 
TABLE I. 
~· actiTity ol poethepar1n pluaa f'raetiODs obtained by ethmol f'raetiOD&tion. 
J'ractiODS 'l'•tecl 
in o.6 Ill phNphate barter pH 7.4 
+ o.6 Ill prehep&r1n plaaaa 
+ 0.3 Ill atmdari tat e.U.aion 
:in o.6 Ill ~mate 
+ o.6 111. ~pl .... 
+ 0.3 Ill atandard tat _.1a1on 
:in o.6 Ill aupemate 
• o.6 111. prehepar:in pla-
• 0.3 Ill stmdarcl tat eaulaion 
:in 0.6 Ill phoapbate barter 
+ 0.6 Ill. preheper:in ple•• 
+ 0 • .3 Ill atanclard tat uml.lion 
:in 0.6 Ill aupemate 
+ o.6 111. preheparin pla-
+ 0.3 Ill. atandari tat aaulaiOD 
optiiiill>iiiaity Gliiirol 1ilue Silbetme .. 
6S S3 
6b 6S 
60 sa 
64 49 
6S 6S 
360 w,o 
370 .380 
360 .370 
36S 420 
3SS 360 
in the 
Fraction 
o-&leb111.:1n• 
Lipid peo~lobulin 
~ l:lpoprote:ina 
Cirul.O)Iil.UIIin 
6. Fraction• :in o.6 Ill phosphate barter p}aninogen, tibr1ll 
I+m- + o.6 Ill preheper:in plama 64 47 360 42o egm, prothrGmbin, 
1,2,3 + O • .)mletan~f~_IIIIIIA~~>q_______ ______ _____ _ _____ :l.ao-_al.ut:inine 
1· 0.6 Ill of poethepar:in tliUIII& + o.6 Ill 
phoaphate barter pH 7. + 0.3 Ill 63 28 370 46S 
standard tat •uleion 
a. o.6 Ill. of nariUl. prelulparin pliUIII& 
+ o.6 Ill phosphate butter pH 7.4 6b 62 36S 370 
+ 0.3 Ill lltandari fat •ulaiOD 
* Eaoh aperD&nt rapreemta en anrage ol two cleterainat101111. 
2. Isolation of clearing faotor bz extracting postheparln pla.a 
with ethyl ether. 
(a) Reagents 
Allhldrellll ethyl ether 
Ethlllol reagent.1 
250 ml absolute ethanol 
2.5 ml 4 M sodiua acetate 
Diluted to 1 liter with distilled water 
CD.yeine Blltfer at pH 8.6 
250 ml ot 0.2 M solution of glycine 
20 ml or 0.2 M soluticn or laal 
Diluted to a total of 1 liter with distilled water 
(b) DevelOpa!lt of the preliminary procedare. 
In order to detelllline the effect. of fat aolvents on the 
lipemia cle .. ing acti v.l. ty present. in the posthepar:l.n plaaa Fraction: 
I + III - 1, 2, ), this fraction waa extracted with solvents or dif-
fering polarity. SIIUill ftlmnes of original posth epar:l.n pla1111a were 
also extracted u controls. The following extractants were usad: 
bmsene1 cyclohexane, carbon t.et.rachlor1de1 petroleum ether (B.P. 30 
26. 
to &J° C.), chloroform, ethyl ether1 3 parts ethanol plus l part ether, 
acetone, ethanol1 and ethylene glycol. 
It was found that til. th the exception of ethyl ether all sol-
vmts used deoreased or destroyed the l~a clearing activity of post-
heparin plasaa and that of Fraction I + In - 1, 2, ). When postheparin 
27. 
plUIIa and ethyl ether, or Fraction I + ni - l, 2, .3 plus s011e water 
and etll1'l ether, were mixed at -SO c. a precipitate was formed, which 
on centrifugation appeared as a s•i-solid inte1pbase between the 
aqueous and ether la;)'IBrs. That interphase C<lllprl slng approximately 
2 per cent of the original pla•a WlWile1 oontained approximately 
90 per cent of the clearing actiYity of the starting material when 
tested by the opt.ical density 11111thod. On COIII.p&ring the lipemia clear-
inc activity extracted with ether from posthaparin pla111a Fraction 
I + III - l, 2, .3, with the lip.U.a clearing activi v extractable 
fl'OII the 811101Ult of pollthaparin plallll& used in obtaining that. fraction, 
it vas found that direct extraction of postheparin plaaaa with etlller 
gins apJrca:imatel;r the a1111e purity and a 1111ch better yield than pro-
longing the procedure by the low tsaperature ethanol plaema fraction-
ation steps. 
The felloving preliminary procedure far the separation of 
crude clearing factor froa posthaparin plasaa vas denloped. Equal 
..ol1111es (5 al) of postheparin plaaa and etll1'l ether are precooled 
separately to 0° c. and then aixed in a test tube at -5° c. for a 
fflfl minutes untU a jelly-like state of the mixture is attained. The 
llixture is kept for 24 hours in a water-alcohol bath at -5° C. By 
tbat time the mixture has separated into an emullli.t'ied upper layer 
and an aqueous lover layer. The llixture is shaken to re11111118 the 
jelly-like state and again is kept in the alcohol-water bath at -SO -c. 
for .3 to 5 dqs and shaken thoroughly once a dq. Then the mixture, 
containing nlDIIIIrous floating particulates, is centrifuged at room 
28. 
t.perature tor 30 IIUlutes at 12,000 g. .b a result of centrituga-
tion the eaulllim separates into an upper layer and a bottom aqueous 
layer separated by an interphase {"Pellicle•) containing the partic-
ulates previously in IIUBpllnsim. 'l'he particulates are densely packed 
and thus fol'lls a saai-solicl pellicle llhich is l'811oved from the tube 
by means of a wooden applicator. 
'l'he above procedUJe 1B readily applicable only it sull 
aaounts of starting aterial are used. By cmtrituging larger vol1111ea 
ot the pla8111&-ether llixture it ill aore difficult to separate the Mill-
Ilion and to obtain the tonaation of a semi-solid layer. In adapting 
the •thod tor the proceasinc of larger aaounts of posthsparin plas-
ma, it bec0111es necessary to introduce sou ohm ges in tbe above pro-
cedure. 
{c) DevelOJ!I8!lt of the final procedure. 
'l'heretore, the tollwing final procedure tor obtaining 
crude clearing factor .troa poethepa:oin humm plasma vas adopted. 
200 Ill of postheparin plasma and aJD mJ. of eth;rl ether are precooled 
separately to 0° c. snd mixed in a 1,000 mJ. vol1111etric tlalllt by 
shaking tar 30 seconds. Then 400 1111 ot ethanol reagent, chilled to 
-5° c. are added and the conteata are mixed by gentl;r Bhald.ng, while 
keeping the container imlllersed in 111 alcohol-water bath at -SO C. 
Mter 10 a:lnut.es of aiJd.ng the pla--etber-ethanol lllixture is placed 
in tour 250 al centrl.f'n&e bottles and centrifuged tor 20 lllinut.es at 
3,000 g and 3° C. {aee page 86 tor illustration). .After centritu-
getion the aqueoua and ether l.a7ers are remGVed by deosntinc and the 
29. 
remaining 11111111-solid substance ("pellicle") ill wallhed 'Ill. th a 25 Ill. 
port;ion of et!JTl-ether at -SO C. lihUe mixing the contents !or 3 min-
ate• with agl.aa11 rocl. Then the ether is decmted and the washing ill 
repeated two 110re time11. The 1 pining ethEr is r&aOYed first b;r 
blowing N2 gaa into ~ bottJ.ell and tinall;r placing the centrihge 
bettles with the 11ubatance into a dalliccator and appl;ring su.cticn 
b;r mems ot a motor Jllimp. From each bottle the slllli-solid •terial 
ill extracted with 20 Ill o! gl.;rcine bu.t!er at pH 8.0 in a Potter-
Elvebjea homogenizer and the 11upematant is collected b;r centrihga-
tion !or 20 minutes at 40,000 g. and SO c. The collected traction is 
dried and.er Y&CUIDII in a frozen state. 5 mg. of thill preparation, 
representing crude clearing tactcr, as wll a11 the remaining plaaaa 
tractions are dis•lved in 1.2 Ill. of postheperin, normal plalllll& and 
on addition o.r 0.3 Ill o.r 11tand.ard tat emulsion are incubated at 37° c. 
in a water bath. The optical densit;r md gl;rcerol concentration are 
d.etemined at 0 tiae and attar 6o minutes o.r incubation. 
The results o.r the11e determinations are reported in Table n. 
---· 
'l'ABLE n. 
Lif!l{tio Aotivitr ot Poath!parln PlaaRa Fruti0118 <btained bz' !tb;rl Ether Extractioo Method 
Exp. S)"St811 Detemineli ioalDG~ in Mici!i Gl.ycerol No. Millilllolee/ f Jol fiaab On ~~f Cll !Oil 
:6iter • -50 • 
l. 1.2 Ill preheparin plaaaa + .6S .6S 3SO .360 
-0.3 Ill standard tat euleion 
2. 1.2 Ill prehepuin plaea + 
residue of ether U,.r + 0.3 Ill 1.16 1.16 .360 3SO 
eteaarcl tat aul.eioa 
3. 1.2 Ill preheparln pl._. + pelliole 
tra l.S Ill poatbeparin plaaaa + .64 .29 3SS S2S 1.23 
0.3 Ill eteadari tat euleiOD 
h. l. 2 Ill infranatant lllpr + .62 .5'6 36S hOO o.2S 
0.3 1111. eteaclard fat euleiOD 
s. 1.2 Ill poatheparm plaaaa 
(starting material) + 0.3 Ill .63 .31 380 S20 loll 
ateaard tat ..W.eion 
6. 1.2 Ill tiatilleli -ter + pellicle 
tra l.S Ill poetheparln plaea + .60 .S7 20 20 
0.3 Ill eteaclard tat •ul.eian 
7. S ag. (dry weight) of nulie ens;yme 
from pellicle extract + .64 .3h 370 h90 0.9h 
1.2 Ill preheparin plaea + 
0.3 Ill ateaard tat •ul.aiOD 
* Eaoh experilllent repreeanta .. &Terage or two determinatiODe. 
D. PROCEOORES FOR THE AT'l'.I!MP'rED PURIFICATION OF CLEARING F.A.CTOR 
In an ef'.t'ort to increase the purity o.t' clearing !actor 
pr~ation the following procedures were aaployed: 
1. Fractionation o.t' clearing !actor oontaining preparation by 
~iUII sulfate. 
31. 
To 40 Ill o.t' the clearing !actor solution obtained by ex-
traction o.t' posthepar:ln plallll& lll.th ether varying quantities o.t' aa-
aoni1Dl sulfate are added a¥1 tlwl solution is brought to 10; 20; 30; 
bo; $0; 6o; 70; 80; and 100 per cent saturation 1d. th respect to the 
8111101liua salt. The appearing precipitate, at different levels o.t' sat-
uration, is ratovu by centrifugation at 40,000 g and at $° C. !or 1$ 
ainutes. Part o.t' the ebtained tractions are dissolved in 0.3 M NaCl 
solution and dislysed against $ pllons or distilled water. 100 mg. 
(wet weight) or respective dislysed and nondial.yzed tractions are 
diuolved in 1.2 Ill pral1sparin plullla and on addition or 0.3 Ill o.t' 
standard !at •ulsion are :lnC11bated at 37° c. :In a water bath. A!'ter 
6o a:lnutes o.t' :Incubation the clearing !actor activ.l.ty is tested in 
duplicate by optical density and gl.;ycerol determination methods. 
'l'be results o.t' tbese deterainations are reported in 
Table nr. 
32. 
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2. At.taaptH pariticat.ion of Cl'llcle clearing factor preparat.ioa by 
adsorption on calcium phopte pl. 
(a) Preparation of calci1111 phospbate gel. 
Calcium phosphate gel wu prepared by' the method ot Keilin 
and Hartree (59). 
33. 
150 1111 of c alciUIII chloride aolution (132 g CaC12.6H2o per li-
ter) is diluted to about 11600 1111 with tap water and shaken with 150 Ill. 
trisodiua phosphate solntion (152 g N~P04.12H20 per liter). The aix-
t.nre is brougbt to pH 7.4 with dilnte acetic acid and the precipitate 
washed three or tear tiaes by' decantation with large voliJIIIes or water 
(15 - 20 liters). The precipitate is finallz washed with distilled 
watar in a centrifuge. 9.1 g of calci1111 phosphate are thus obtained. 
other Reagentas 
Physiological saline (870 ag. NaCl. in 100 Ill. water) 
0.1 M citric acid (9.6 g citric ac:!.ci in 500 Ill. or water) 
(b) Procedure 
10 Ill of clearing factor solutiaa are mixed with 5 g or 
treshl.z made calcilllll phosphate gel mel the mixture is centrifuged at 
3,000 g an1 SO c. tor 10 minutes. Tbe collected precipitate is twice 
extracted vi th 40 1111 portions ot physiological saline followed by ex-
tractiCirl with l,o 1111 of 0.1 M ci t.ric acid. Attar each ext.raction the 
aixtare ia separated by' centrifugation at 31 000 g and _sO c. tor 10 
llinutea. The obtained ext.racts are lzophilized and the 15 mg. of 
solids from each extraction respectively, are dissolved in 1.2 Ill. of 
noraal preheparin plasma and on addition ot 0.3 1111 standard tat emulsion, 
.34. 
the lllixture is incubated at .37° c. in a water bath. .After 60 llinutes 
or incubation the clearing factor aoti~ty or these fractions is test-
ed in duplicate by optical density and glycerol determination methods. 
The results of these determinst.ions are reported in Tabl.e IV. 
Page .35 missing in !lUIIbering onlJr. 
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'!'ABLE IV. 
Lipolzt1c .l.UYitz Pruent in the Bluates Obtained atter w .. hing of calciaa 
Pllospbate Gel with .ltlso:rbed. Clearing Factor 
* 
aiaiige iii 
E:xp. SJ8taR Dete:nnined 
lfo. 
1. 15 ag. of starting -terial 
(crude clearing taetor) 1111. 68 27 370 530 1.16 
1.2 Ill prehep&r1n pla- • 
0,:1111 standard tat •ulaien 
2. 15 ag. of solids trc~~~ lst VUh· 
ing with pbJ81olog1Ml. nl1ne in 65 63 360 365 
-1.2 Ill prelulpar1n pl••• + 
o.~ 111 RllnUl-d rat. •ullliaa. 
3. 15 ag. of 110l1da traa 2nd wull-
ing with pbJIIiolopoal H1 ine :In 63 60 355 360 0.18 
1.2 Ill prebllp8l'in p~ + 
0.3 Ill standard tat ..uLaiCil 
h. 15 ag. of solids from lst vub-
:lng with 0.1 M citric acid in 6h 26 360 510 1.09 
1~2 Ill prebepar1n pluma + 
0.3 Ill standard .tat ..W.sicm 
5. 15 ag. of solids .troll 2nd VUh-
ina with 0.1 M eitric acid 1n 6h 58 365 315 
-1. 2 Ill preheparin pl.aBIIIa + 
0.3 ml standard .tat eaulsion 
6. 15 mg. of citric aal.d in 
1.2 Ill prehepllrin pliUIII& • 6J 60 370 370 
-0.3 Ill st.andard .tat •ulsion 
* Baab up~ rillamt represente an average o.t t.vo date:ndnstions. 
3. Fractionation of al.earing factor containing preparation by 
increasing bzdr!gen ion concctrat.ion. 
37. 
The selli-solid layer (obtained by extracting 50 ml of poet-
heJB rin plallll& vi th ether) is llinced with 20 ml of 0, 03 M sodilllll chlor-
ide solution in a cPotter-ElvehjeB hoaogenizer and the supernate is col-
lected by cantrl.tagation at 4,000 g and rfl c. tor 20 minutes. The pH 
ot the starting material is 7 .o. B7 the addition of lllllll.l llliiOUllts of 
0.2 N HaL the hydrogen ian concentration of the solutiom is brought up 
to pH 6.8; 6.5; 6,0; 5.5 and 5.0, The appearing precipitate attar each 
pH adjustment is r•aved by cmtrltqation at 20,000 g and 5° c. tor 
10 minutes. Duplicat.e saaples of 50 mg. (vet veigbt) of each precip-
itate are extracted with 0,6 Ill ot gl.Tcine butter at pH 8,6, The mix-
ture is centrl.tugad tor 5 llin1ttes at 1,000 g and the respectiTe auper-
natmts are transferred to ColEIIlan microcuvettea. To each lllicrocuvette 
0,6 Ill preheparin plallll& and 0.3 Ill of stsnciar'll tat elllllsion are added 
and the saaplea are in011batad in a vatar bath at 37° c. At 0 t:l.llla md 
atter 5 llli.n.; 10 Jilin,; 20 min.; 4o lllin. end 6o min. ot incubation the 
lip8111ia clearing actinty is tested by the optical density method. 
The results of these claterlllinations are reported in Table v. 
TABLE V. 
Lipa!i.a CJ.earing .loti vity or the Fractions . O,tamed by Inoreuing lfldrog!ll Ie Concentration 
In a Crwle atearini Factor Preparation. 
* ~in ~al. ~sitl Ellp. Systa Detendned -ol aton 
No. 0 w1n. 5 w1n. nJ JI1Do m win. mJ .. D. 
5lj """· 
l. Starting -terial 0.6 Ill 
(crude eDZJIII8 prep.}+0.6 Ill preheparin plaaa 70 61 48 .36 31 24 
at I!!! 7 .o +0.3 m1 standard rat •ul. 
2. Preoipitate :ln o.6 Ill slTcin• buf'rer 
at pH 6.8 + 0.6 Ill. preheparin pluJ!a 61 41 38 28 24 22 
+ 0.3 Ill stand•rd rat ..w.. 
). Predpitate in 0.6 1111 &17cine buf'rer 
at pH 6.5 + 0.6 Ill preheparin pl .... 61 44 35 28 25 24 
+ 0.3 Ill atmclard rat -:1.. 
4. Precipitate in o.6 Ill gqeine buf'rer 
at pH 6.0 + o.6 m1 preheperin JU .... 61 48 44 39 31 27 
+ 0.2 Ill atmdard. rat -.ul. 
5. Preoipitate :ln o.6 m1 glycine buf'rer 
at pH 5.5 + o.6 1111 prehepar:ln plae.a 61 54 49 41 34 30 
+ o.) Ill lltandard rat -ul. 
6. Precipitate :ln o.6 Ill. glycine buf'rer 
at pH 5.0 + o.6 Ill prehepar:ln plaaa 51 53 52 49 45 41 
+ 0.3 m1 standard rat uul. 
7. 0.6 Ill or rua1n1ng solution pH adjusted to 7 .o 
o.6 m1 prehepar:ln plasma 68 67 67 67 67 67 
0.3 Ill. standard rat ..ulsion 
8. 0.6 m1 gl.yc:lne buf'rer pH 8.6 
0.6 m1 preheparin }Uaaa 65 64 64 64 6) 6) 
* 
o.) Ill standard rat aulsion 
Each exper:tlllen'E represents an average ol two aeterillliiat!ons. 
E. ISQL.ATICII AND PIJRIFICATICII OF CLEARING FAC'l'OR BY REPEATED 
IXTRACTIONS WITH ETHYL ETHER 
39. 
100 al of postheparl.n plasma md 100 al o! eteyl ether are 
precooled to 0° C. ami llixed 1n a 11000 llll. wluaeilric fiask: by sbsk:1ng 
tor 30 eec011da. Than 200 al o! ethmol reagent, chUled to -5° c. are 
added ami the contante are mixed .for 10 minutes at -S0 c. The llixture 
is placed in !our 250 Ill. CEiltrituge bottles am cuntri.tuged at 31 000 g 
md -3° c. !or 20 llinutes. The ether and aqueous layers are ranoved 
ami the stni-solid layer (•pellicle•) rema:!n1ng in the bottle is ex-
tracted with three 2S al portions o! eteyl etll!lr. Ether is decmted 
and COIIIpletely removed by evaporation 11r1der vacuum. The precipitate 
is extracted with 40 al o.r g~cine bo.!!er at pH 8.6 and the supernat-
ant is collected by oentritugation at 31 000 g and SO c. !rr 20 llinutes. 
The collected supematmt is reterred to aa Fraction I. One and one-
halt al ot the supernatant vas lyophilized !or dete:naination fL lipo~ic 
ution, mel o.S al was taken tor protein concentration tests. The re-
uining 38 Ill. at the supernatmt md 38 al ot ethyl ether are precooled 
to 0° c. md llixed in a 250 Ill. Erlanmeyer flask. The contents are con-
tinually w1xetf tor S minutes while the fiaak is k8pt in an alcobol-
water bath at -S0 c. On centrifugation at 31 000 g and -3° c. tor 20 
llinutes, !our la;?l!lrS are obtained trom the above mixtu:re : precipitate 
on the bottDIIl of the tube, aqueous la;yer, ether la;yer, and semi-solid 
layerat the interphase o! aqueous md ether layers. The liquid phases 
are decanted, the prec:1pitate ed the semi-solid layers are combined 
md extracted witb two 25 llll. portions ot ethyl ether at -5° c. The 
etger is decanted and eeapleteq 8Y&pcrated. arder YaOUUIJI, The ob-
tained precipitate is extracted with 40 Ill of glycine buffer at pH 
8.6 and the auplll'natant is collected after cmtrifugation fer 15 
llinutes at 20,000 g aad ,a c. The collected supernatant is re£erred. 
to as Fraction II. One and one-half Ill of th9 supernatant vas ly-
ophilized for lipolytic actbity detel'lllinations and 0.5 ml vas taken 
for protein concentration tests. The remaining .38 Ill of supernatant 
!IO. 
are extracted with .38 ml of ethyl ether by repeating the abon de-
soribefi procnure. The obtained 40 ml of supernatant. (by extracting 
semi-solid and solid lqers with glycine buffer) represmts Fraction III. 
One and one-half ml o£ the Fraction III containing solution is lyophil-
ized for lipolytic action cletel'Aination and 0.5 Ill is taken out for pro-
tein concentration tests, The remaining .38 ml of supernatant and .38 ml 
of ethyl ether are precooled to 0° c. 11r1d again aixed together, follow-
ing the prerloualy desCJribed. procedures. After the cctrifugation four 
layers are obtained !l'GII the mixture. At this point cnq the semi-solid 
layer is rcoved (by me11r1s of a voodan rod). It is washed with 25 ml 
of ethyl ether at -5° c. aad extracted llith 30 ml of glya!.ne buffer at 
pH 8.1. The collected n.pernatllllt, after CEiltrifugation for 20 minutes 
at 20,000 g and ~ c., is reterred to as Fraction IV and represents the 
final traction containing purified clearing factor. One and one-half ml 
or the Fraction IV containing solution vas taken for the protan concen-
tration tests and the rcld.ning material is lyophilized and stored in 
the dry state at -~ c. The IIUIIIIIIIl'Y of the steps taken for isolation 
and purification of clearing factor by the ether extraction 1118thod iB 
given in the attached nov sheet. 
100 m1 100 Ml. zoo nu:------------------------
Postheparin Plasma + Ethyl Ether + Ethanol Reagent 
Mixture kept at -SO c. for 10 minutes 
Centrifuged at 3,000 g and -SO c. for 20 minutes 
'~ Intennediate 
semi-solid layer 
(pellicle) 
92-95% activity 
._t.._ 
Ether layer 
No activity 
Washed 3 times with 25 Ill portions 
of ethyl ether at -50 c. 
Intennediate 
semi-solid layer 
(pellicle) 
90-95% activity 
Extracted with 40 ml glycine buffer 
of pH 8.6 and centrifuged at 20,000 g 
and +5° C. for 20 minutes 
Ether layer 
No activity 
v 
Infranatant 
aqueous layer 
5-8% activity' 
Supernatant 
80-82% activity 
FRACTION I Precipitate 
No activity 
+ 40 ml ethyl ether, mixed for 5 min. 
at -5o c., centrifuged at 3,000 g and 
-5o C. for 20 minutes 
Intermediate 
semi-solid layer 
45-50% activity 
Precipitate 
25-30% activity 
Ether layer 
No activity 
Precipitates combined and twice extracted 
with 25 m1 ethyl ether at -5o c. 
Precipitate 
75-80% activity 
Extracted with 40 m1 glycine buffer 
Centrifuged at 20,000 g, + 5° c. for 
20 minutes 
Supernatant 
No activity 
Supernatant 
70-74% activity 
FRACTION II Precipitate 
No aoti vi ty 
+ 40 m1 ethyl ether, mixed for 
5 min. at -5° c., centrifuged at 
3, 000 g and -5° c. tor 20 Dd.nutes 
Intennediate 
semi-solid 
4o-45% activit,-
Precipitate 
18-20% activity 
~ Ether layer 
No activity 
Precipitates combined and twice extracted 
with 25 m1 ethyl ether at -5° C. 
Precipitate 
65-70% activity 
Extracted with 40 ml glycine buffer 
centrifuged at 20,000 g and +5° C. for 
20 minutes 
Supernatant 
65-68% activity 
FRACTIOO' lli 
40 m1 ethyl ether mixed for 5 min. 
at -5° c., centrifuged at 3,000 g 
and -5° c. for 20 minutes 
J, 
Precipitate 
No activity 
Intermediate Prec pitate 
semi-solid layer 2-5% activity 
55-60% activity • 
Ether layer 
No activity 
Washed with 25 m1 ethyl ether at -5o C. 
Extracted with 30 ml glycine buffer 
Centrifuged at 201 000 g and so c. for 
20 minutes 
Supernatant 
~"-~?It .,.+:hri +.v 
FRACTION IV Precipitate 
No activity' 
Aqueous layer 
1-5% activity 
Aqueous layer 
No activity 
Ether layer 
No activity 
Aqueous layer 
No activity 
The lipo~c activity ot the isolated tractions is tested 
in duplicate br optical denait;r and tree tatty aaid determination 
JUthod.a. S ag, of a respeetin dr,r traction are dissolved in 2.0 Ill. 
ot nOl'lllll. preheparin plaaa. On inClllbation for 60 llinutes with O.S Ill 
standard tat 811111ls1.on the chsnges in eptl.cal dansi ty and llii.&sterified 
tatty acids are determined, 
The protein content of the ieolated tractions vas determined 
br the tollolling Biuret •thod (90). 
(a) Prepara1ion of Biuret Reagent 
To a solution of lS ga, ot copper sulfate with five waters 
ot bJdration (l0.2S p. of copper chlorilie with two waters of hydra-
tion) in 2SO ml of water, 7S Ill. ot etlJTlene glycol are added, followed 
br 150 gm. ot sodiiDil hydroxide in aqueous solution end 1he lilole miX-
ture ud.e ap to SOO ml. The solution is transferred to a large Erlen-
meyer fhsk, covered with a watch glass, and heated 4 hours on a steam 
bath. The solution is f!.ltered after cooling. 
(b) Procedure 
One-halt llll. aliquot& ot the respective tractions in solution 
are placed in 2S Ill Erl8llllleyer fiasks and brought to 10 ml by eddition 
ot O.lS M sodia chloride, A blank is set up using 10 ml of the O.lS M 
aodiUIII chloride. In each series of readings is also included a bovine 
serua albWIIin standard containing l ml of 1.0 per cu albumin (the 
standard is chedced by aicro Kjeldabl analysis, and the tactcr 6 • .30 
used to convert N into protein content) and 9 ml of O.lS M sodiua 
chloride, 
To the contents of each nuk 18 added by swirling 1 m1 of 
Biuret reagent, After standing 20 llinutes at roCllll temperature, the 
solutions are read against the blank in a Klett colorimeter, using a 
filter transmitting maximally near SSO millimicrons. 
Calculation: 
volume of solution unknown r~ • mg. protein 
volume of lliquot x standard re x 10 in the S8111ple 
The results of these determinations are reported in Table VI. 
The additional data on clearing factor purification is presented in 
4.3. 
Table vn and is partially derived frCllll the results reported in Table VI. 
In order to assure that the same concentration of clearing factor 
is used in a given set of tests, an arbitrary unit of clearing factor, 
at this point, is introduced: 
One unit is the 11111ount of clearing factor, which on incubation 
.for 6o minutes at 37° C, with 0.2 ml o.r normal preheparin plasma and 
2,5 ag, of coconut oil (present in the .rom o.f O,S ml of standard 
* 
•ulsion ), increases titratable acidity by one millimicroequivalent 
or l x lo-9 of an equivalent. 
* For description see page 18, 
44. 
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TABLE VII. 
IMlat1Gil and Purification oE Clearing Factor bz Extruticn 
!'rail Postlleparin RWIIIIl PlUIIIa with Et!!yl Ether 
100 Ill ot starting -terial. 
Totat Totat Units 
Fraction Protein Unite* per mg. Purification 
ag. ot protein 
Postheparin 1,050 125,000 17.7 l 
J!lUIII& 
Frution I 224 102,000 456 26 
Fraction II 92,400 654 37 
Fraotion III 85,100 740 41.8 
Fractien IV 55 64,400 1,170 66 
* cne unit is the 111110unt ot cleering factor which on incubation tor 
60 minutes at 370 C. with 2 Ill ot nol'lllll preheparin plasma and 
2.5 ag. et coconut oil (present in the fora ot 0.5 Ill or standard 
emulsion) increases t1tratable aciditzbz one m1111m1croeqllivalent 
or l x l0-9 ot an eqllivslant. 
45. 
Yield 
! 
100 
81.6 
13.9 
68 
51.9 
II. PROCEDURES FOR THE D!!SCRIPTION OF PHYSIOCW!MICAL PROPERTIES OF 
ISOLATED CLEARlNG FACTOR 
A. PURITY OF THE ENZYME PR!!PARATIOO 
The purity of the fractions with clearing factor activity 
vas tested by electrophoretic and ultracentrii'ugal procedures. 
l. Free bounda;r electrophore!!! 
llO mg. of Fraction IV, obtained through successive etllilr 
extractions of postheparin pla1111a, are dissolved in 2.4 ml of water 
46. 
md are set overnight tor dialysis against 2 liters of barbital•sodi1111 
citrate buffer of pH 8.6 and ionic strength of 0.1. The electrophoretic 
analysis is carried out in a Perldn-'I!:l.Der Tiselius electrophoresis 
apparatus, modal 58, using barbital-sodi1111 citrate buf'ter of pH 8.6 
and ionic strength 0.1. 
2. Ultracentr.Lfugal analy&is 
30 mg. of Fraction IV, obtained after successive ether 
extractions of postheparin plasma, are dissolved in 1.2 ml of O.l M 
sodiu chloride and subjected to centrifugation in an E t;ype Spinco 
0 
analytical centrifuge at 56,100 RPM and 22 C. tor 80 minutes. Pic-
tures of the sedimentation pattems are taken at 0, (time at which the full 
speed is achieved) 4, 6, 16, 24, 32, 38, 44, 64 and 80 minutes. 
The pattems obtained are presented in Figs. l and 2. 
47. 
FIGURE 1. 
Electrophoretic Pattern of Purified Clearing Factor Preparation 
48. 
FIGURE 2. 
Ul tracentrifugal Pattems of Purified Clearing Factor Preparation 
B. STABILITY OF THE PURIFIED CLEARING FAC'l'OR 
The stabilit7 of the clearing factcr vaa eTaluated. in 
regard to its peyaical state, t~erature and requirement of protec-
tive protein. 
Samples containing 2,000 units of clearing factor are 
prepared in triplicate :In the following 1118lners 
(a) in the form ot a dry powder 
(b) dissolved in 0.6 Ill of veronal blfter of pH 8.6 
(c) dissolved in a llixture of o.6 Ill of veronal butter and 0.4 Ill 
ot 10 per cent bovine al.bamin solution (the resulting pH is 8.1) 
'!'he above prepared s•ples are kept at -20° c., 0° c. and 
2SO C. for 7 days. Then the pbyeical state of the saaples are acljust-
ed so that all ••plea are dissolved :In a mixture of 0.8 Ill veronal 
butter and 0.4 Ill 10 per cent bovine albumin solution of pH 8.1. On 
acldition ot 0.3 ml of standard tat emulsion to each tube the samples are 
incubated at 37° c. tor 30 llinates and the clearing factor activity is 
cletemined. by optical. densit7 method. All a control the act1 vi1:jy ot 
21 000 units of treshl7 prepared GZ11118 {dissolved in the same varcnal-
al.bullin mixture) is cleterained. 
The results of these ciet8Diinations are presented :In 
Table VIII. 
TABLE vm. 
Btfeots of 'l'!!IIPerature and Protein on the Stability ot Clearing Paetor Solution• 
Clearing Pact.or 
Kept for 1 Daya 
Dry tom 
Disaolftd 
:In Vercal. 
Butter 
Dissolnd. in 
Veronal. Butter 
+ .Ub'llllrln 
.6S • :,;; .32 
.63 .!A 
.66 .40 
* SFE ,. Standard. fat aaulsion. 
.64 .32 .66 
.64 .49 .6S 
.6S .bh .66 
.36 
.S7 
.,.,. 
For control purposes 2,000 units of fresbJ.T prepared ens:JIII8 were dissolved in a Veronal.-Albulllin 
llixt.ure and the optical densit;r was deterained. The reading was .64 at 0 time and .31 at 6o llin. 
ot ineu.bation. 
Each figure represents an average of three deterainatians. 
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C. T~TS ON THE CHEMICAL COMPOSITION CF 'IliE PURIFIED CLEARING FACTOR 
1. Detennination of total protein. 
The protein content of clearing factor preparations ob-
tained by extracting postheparin plasma with ether was determined by 
the biuret method (page 42) and the results are reported in Table VII. 
2. Determination of phospholipids and cholesterol. 
The cholesterol and phospholipid content of the clearing 
factor containing Fraction IV were determined; employing the revised 
method of Fiske, C.H. and Y. Subbarow (21) for phospholipids determin-
ation and Bloor, W.R. and A. Knudson (8) for cholesterol. No choles-
terol and only traces of ph6sphorus representing phosphatides were 
found. 
3. Determination of the presence of lipoprotein and g1ycoprotein 
in the clearing factor preparation. 
1he presence of lipoprotein and glycoprotein in clearing 
factor containing Fraction IV was determined by the staining methods 
of Swahn (120, 121) and of Koiw and Gronwall (61). 
A few drops of a staurated so:j.ution of clearing factor are 
placed on 3 strips of Whatman #1 filter paper and dried. Then the 
strips are fixed in an ethanol-formalin solution and stained with 
Sudan black B for lipoproteins and with Toluidine blue for glyco-
proteins. For control purposes dilute solutions of beta lipoprotein 
and heparin are stained by the above methods and the colors developed 
are compared with the tes~ strips. By these methods no lipoproteins 
or glycoproteins were detected in the clearing factor preparation. 
TII. KINE'l'IC S'l'UDIES OF THE ISOLA'l'ID CLEARlNG FACTOR 
A. Dli'EBMINATICfi OF THE EFFECT OF T BMPERATURE Cfi THE REACTION 
VELOCI'l'Y OF CliJ:ARING FACTOR 
Ta the teet tUbes oonta1ning 1.0 al of veronal butter of 
pH 7 .a, 0.2 al of lO per eent albadn solution and 6,000 Ullits of 
clearing factor; 0.3 Ill of standard fat •uleion is added and the 
contents are incubated at various tanperaturea for lS llinutee. At 
S2. 
At the beginning and the e11d of incubation the lipolytic activity of 
the d.aplicate saplea are tested by detel'lllilrlllg the changes :In aptioal 
density and the conce11tration of Ullaeteritied fatty acids. 
The results of these cletendnations are presented :In Table n 
and :In Fig. 3. 
B. lf1'ElHINATICfi OF THE EFFECT OF HlDROaKN I(Jl tlll<DTRATION ON 
THE REACTICfi VELOCITY OF cmARIHG FACTOR 
To the test tubes containing 4,000 Ullits of clear:lng factor 
dissolved in l.O Ill citrate or veronal buffers of varying pH., 0.2 al 
of lO ptr cmt alb11111in solution and 0.3 Ill of etandard tat emulsion 
are added md 1he aixture ie inc.j)ated far l5 lliuutes at 37° c. At 
the beginn:lng and 1be md of inCJlbation the non-esterified fatty acid 
content is deterllined :In duplicate. 
The results of these dsterm:lnations are reported :In Table I 
and in Fig. 4. 
c. m.-.rERMINATICfi OF THE DftCT OF CONCENTRATION OF CLEARlNG FACTOR 
Clf TilE VELOCITY OF THE REAC'l'ICfi 
Daplicate samples containing 3.6; 7 .2; 14.4; 28.8; 43.2; and 
S7 .6 ag. of clear:lng factor protel.n (Fraction IV fl'Cllll ether extractions 
of postheparin pla~~aa) lll'8 dieaolTed in 6.0 Ill of preheparin nomal 
pl ... a rupectiTely, ad on addition of 1.$ Ill of standard tat emulsion 
are in011bated at 37° c. in the water bath. At 0 t:illle and 4 and 8 lllin-
utes of incubation 1.0 Ill aliquots are taken ad optical density and 
l:acm-esteritied fatt;r aal.ds are detel'llined. 
Tb.e reaults of these deteainations are reported in T~le XI 
and in Fig. $. 
D. DE'flllMINATION OF THE EFFECT OF SUBSTRATE CCilCENTRA.TION Cll 'l'HE 
REACTICil VELOCITY C6 at.EARIHG PACT<Jl 
Te the duplioate saples containing 2,000 units of cl.esrine 
factor dissolTed in 1.0 Ill of preheparin norul. pl&III&J o.03J o.o6J 
0.09J O.l2J 0.15 ad 0.18 Ill of st.adard tat aaulsian are added ancl 
the llixtures are incubated at 37° c. for 4 llinutes. Atter 4 llinutes 
of incubation and at 0 time the concentration of non-esterified tat~ 
acid in the 118111ples ill detemined. 
The resultll of these det81'11inations are reported in Table11 XII 
and XIII and in Fig. 6. 
'!'MILE II. 
Ettect ot 'l'!IJ)!l'&ture on Reaction Ve1eciy ot aLearins Faeter 
* 1 X 1rP 
Ill •• 02 'R ~Microequ.balenta ot LOg-or lf!cr.iqUirilente 
!Jrp. 'l'.ap. in 'rllllp. in 'Ra£11 'l'itratab1e Aoidit7 ot 'l'itratab1e Aoidit7 
'Ro. Centrigroade Abeol11te T Used per Salllp1e 
De ea 
1. 0 m 36.6 .DOl~ .072 2.67 
2. 2 276 32.9 .003 .12 i.18 
3. 10 283 3~.3 .00h2 .2~ i.32 
4. 20 293 34.1 .0082 .42!) i.63 
s. 30 303 3~.0 .0016 .800 !.90 
6. l1. 310 32.2 .024 1.200 o.oa 
7. 40 313 31.9 .0233 1.17 0.07 
8. 42 318 31.4 .0131 0.62 I.8l 
9. .50 323 30.9 .006 o.24 i.38 
10. ss 328 30.2 .003 Q.1S !.16 
* Each uperlment repreeente an average ot two detel'lllin&tione. 
Reaction time = 15 minutes. 
FIGURE 3. 
ARRHENIUS PLOTS FOR THE ACTIVATION 
TEMPERATURE OF CLEARING FACTOR 
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FIGURE 4. 
THE EFFECT OF HY OROGEN ION CONCENTRATION ON 
THE REACTION VELOCITY OF CLEARING FACTOR 
1.2 
3 4 5 6 7 8 9 10 pH 
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TABLE XI. 
Et.f'eot of' Clearin& !'actor Ooncmtration on the Velocitr of' Lipoqtic Reaotioa 
Blip. Clearing :raotor 
No. aa ag./111 Protein 
1. .. 0.48 .63 ,61 .60 1.6lh 1.62.5 1.638 
2 • o.96 .& .59 ..58 1.602 1.6J, 1.662 
.). 1.92 .& .~9 .58 1.61~ 
. -------------~------~------ ______ :i' 1.6SS 1,689 
4· 3.8h .63 .~ .g 1.610 1.670 1.720 
.5. S.73 .63 .53 .48 1.612 1.672 1.746 
6. 7.68 ,62 • .5'1 .43 1.610 1.680 1. 728. 
* Each uperilllent represents an &Ter&ge of' two deteminations. 
FIGURE $. 
EFFECT OF CLEARING FACTOR CONCENTRATION 
ON THE VELOCITY OF THE LIPOLYTIC REACTION 
4 6 8 10 
mg. PROTEIN 
REACTION TIME 4 MIN . 
59. 
vvo 
TABLE m. 
Et.f'eot o.f' Sublltrate Conomtration on Cl.ear:lag ll'actor AoUvitr 
* 
COoonut oU 'l':lllle ol Incabation IIH'l'eMDoe_iil ____ cnau.gem-Mfcre-
Bxp. Presmt (5 •'»· li •'"• MioroequiYalents equivalents o! 
No. Micrograma/1111 0.02 R o.02 H per Sap1e titratable acidity 
NaOH NaOH Titrated 
1. 2S .0309 .0317 .013 .017 
.0311 .0316 
2. so .0313 .0320 .018 .0.30 
.0.310 .0318 
3. 7S .0.311 .0.322 .02.3 .ob2 
.o~~ .0.321 
h. 100 .0308 .0.32.3 .026 .oso 
.0312 .0.323 
s. 12S .0301 .032h .029 .OS7 
.0303 .o32S 
6. lSO .0.3lh .0.326 .0.31 .062 
.0.307 .0.325 
7. Control .0311 .o3lh .006 
No substrate .03lh .0311 
a. Standari .o4oh 
.oh06 
* Each uperiment represents an average o.f' two dete:na1nations. 
61. 
TABLE xm. 
Etfect ot Sllbstrate Conoatl'ation on Clearing Factor Acti'Yitz 
* E:lp. Coconut OU Cocanut OU 1 Relative Velocity 1 
No. Microgr•e/ Hicrlllllolee/** SUbstrate M:l.croequivalente Reiat!ve 
Ill Ill Acid Velocity 
1. 2~ .027 37 .017 29 
2. ~ .osh 18.~ .03 33 
3. z~ .081 12.3 .042 24 
:..4. 100 .108 9.3 .02 20 
2· 122 ·~2 7.4 .o2f. 17 
6. 1$0 .162 6.2 .062 12 
* 
Each experillct represents 1111 average of two utennillationa. 
** 
Molecular weight of cocanut tat is cmaidered 923 and that ot 
tatt;r aeida 277. 
FIGURE 6. 
EFFECT OF SUBSTRATE CONCENTRATION 
ON CLEARING FACTOR ACTIVITY 
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E. SUBSTRATE SPECIFICI:TY FOR CLEARING FAal'OR CATALIZED BEAal'IONS 
Elllplo;ying the uperiMntal conditions as unitol'lll as possible 
the action ~ the cle~ factor on the following substrates were 
testedt 
1. Stmdard tat -ul.sion 
(a) Preparation ot substrate 
One part of standard tat umlaion and 19 parts of water. 
Kept at -SO c. 
(b) Procedure 
To a llixture containing 8.0 Ill veronal batter ot pH 8.6, 
63. 
h.o Ill of 10 perc mt alblDin solution and 301000 units of dissolved 
clearing factor; 3.0 Ill of lt20 diluted standard tat -ulsion are added 
and the llixture is incubated in a water bath at 37° c. After 01 S, 101 
201 hO and 60 ainutes of incnbation, 1.0 Ill aliquot of the aixt11n is 
talcm in duplicate and the cone Sltration of non-esterified tatty acids 
is dete:nrlned. 
2. Triacetin 
(a) Preparation of substrate 
12.0 ag. ot triacetin in l.S Ill ot distilled water. 
(b) Procedure 
To a aixture containing 8.0 Ill veronal buffer of pH 8.6, 
h.o Ill of 10 per cmt alblllllin selution 111.d 301 000 1Dlits of dissolved 
clearing factar; 3.0 Ill of triacetin solution are added and the mixture 
is incubated in a water bath at 37° c. At O, S, 101 20, hO and 60 min-
ute tiae intervals 1.0 Ill aliquot of the mixture is taken in du.plicate 
and the concentration of non-esterified fatty acids is detel'lllined. 
6h. 
3. C&lOIIicrons 
(a) Prep!l"ation or nbetrat. e 
A normal ule blood donor, atter a tatv breaktaet at 7 A.M., 
<lis given a pint or bea.,. cre11111 at 10 A.M. and 3 hours later blead is 
collected in ci tratecl blltt.llee. Arter 30 ainut ee centri tugation at 
21 000 g, 250 al ot lipelllic pluaa are collected and the ctq"lOllicrone 
separated by repeated oeo.tritugation at 20,000 g tor 30 lllinutee. The 
obtaill8d top 01'881V layer is twice washed in ph;rsiological eal.i118 and 
the collected obTlomiorona are IIUIIpended in S al c£ distilled water. 
From tbia stock eolnticn a final dilution is prepared eo that adding 
0.3 al or chylomicron preparation to 1.2 Ill or venmaJ. butter would. 
giTe optical density reading or .6S. 
(b) Procedure 
To a mixture containing 8.0 ml veronal butter ot pH 8.6, 
4.0 al or 10 per cent albumin solution and 30,000 Wlits or dissolved 
clearing factor; 3.0 Ill or above cbTlomicra preparation are added and 
0 tbe lllixture is incubated in a water bath at 37 c. At o, S, 10, 20, 
4o, and 6o minute intervale, 1.0 Ill aliquot or the mixture is tskm in 
duplicate and tbe concentration or non-esterified ratty acids is deter-
mined. 
4. Beta lipoproteins 
(a) Preparation or substrat.e 
To 10 luateroid tubes each containing S al or pla&Ra obtained 
fr• nonaal, tasting per110n1 4 Ill of sodi11111 chloride solution of epecific 
gravity 1.1343 are added and the aixture is centrifuged in a Spinae 
1 type centrifuge at .36,000 RPM and 22° C. for 16 hours. One llilliliter 
of the top lqer is removed by means of syringe and needle. This repre-
sants beta lipoproteins of specific densiv 1.04 (67). 
(b) Procedure 
To a mixture containing 6.0 ml veronel but'fer or pH 8.6, 
.3.0 Ill or 10 per cent ubwllin solution md 22,$00 units or dissolved 
clearing factor; 2.5 Ill of the collected beta lipoproteins are added and 
the mixture is incubated in a water bath at .37° c. At Oi,lO, 20, md 60 
minute time intervals, 1.0 Ill uiquot or the mixture is takm in dnplicate 
and the concentration of non-esterified fatty- acids is determined. 
F. DEI'ERMINATION OF ALBUMIN AND CALCIUM ION INFLUENCE (II THE LIPOLITIC 
ACTION OF CLEARJNG FACTCil 
The following llixtures are prepared in chplicate and after 
incubation at 0 tille at .37° C. for .30 Jl:inutes, the concentration of 
non-esterified ratty- acids is deterained. 
(l) 1.2 ml buffer + 0 • .3 Ill standard f'at emulsion + 2,000 units of' 
clearing factor. 
(2) o.B ral. but'fer + 0.4 Jill 10 per cent albuain solution + 0 • .3 ml 
standard f'at 8111ulsion + 2,000 unite clearing factor. 
(.3) 1.0 ml buffer + o.a Ill 5 per cent cslciua acetate solution + 
2,000 units clearing factor. 
(4) 0.6 Ill buffer + 4 ml albumin solution + 0 • .3 ml standard fat 
emulsion + 0.2 Ill cuciua acetate + 2,000 units clearing factor. 
(5) Control consists or 0.8 Ill buffer + 0.4 Jill albumin solution + 
o.j i1 stmdard rat elllllsion md no enzyme. 
The results of' these determinations are reported in 
Tahl es XIV and XV. 
'f.ABL'S XIV • 
Lipolltio Aetbitz ~ CJ.earing Faetor in tAe Presenoe ol Ditt-t Substrates 
* Blip. Substrate Aao•t ot Microequivalmte ot 'fitratable Acidity A 
JJo, 'friglyceria Alter InoubatiCIIl 1li th Sabetrate .. , Acid After 
_0 idii. - )_iijii. ~ 111n. m w1n. lilS "'"· OlJ m1n. 6o llin. 
-l. SFE l.Sg. 0,883 0.986 1.090 1.~3 1.321 1.43~ 0.~2 
2. 'friaoetin 1.5 !!i• 0,880 0.878 0.884 0.880 0.884 0.888 
3. CbylOIIIioron 'fo give optical o.885 1.019 1.161 1.385 l.S47 1.687 o.653 
densitz: 6~ 
Ia. -lipoprote:l.u te give optical 1.022 - 1.062 1.142 
-
1.195 0.173 
t~mllity 65 
5. sn: Ccllltrol 0,880 0.880 0,880 o.88o 0,884 0,884 
-No Enzpe 
6. Control 
-lipoprotein 1.021 1.022 1.020 1.020 1.021 1.021 
No Enz:rme 
7. Standard 0.840 
* Each uperl.llent represents en average ot two determinatiODa. 
** sn: = Standard tat a~~ulsion. 
'l'ABLE XV. 
Cal.oi- Ion mel .llbwd.n Innucoe on the t1polztio Action ot Cl.eariDg l"aoter 
* 
S:rataa UHd -
** Hi~nlerrtl if .. CbiDP 1D EJ:p. Batter ¥= Betii-!!f"rote'n• ~· §Ji Mioroequival.tlllte ot liEP'.l tNr Ineub. ~ • :!ll "'"· lfo. Ill 'l'itratab1e Acid 
1. 1.2 
- - -
o.3 0.870 0.872 
2. o.8 o.4 
- -
0.3 0.872 1.17 0.30 
3. 1.0 - - o.2 o.J .Q._~-- ___ 1.oos __ _ _ o.13S 
4. 0.6 o.4 0.3 ();'2 
-
0.89$ 1.18S 0.290 
s. o.8 0.4 
-
o.3 0.868 0.870 
-No enzyme 
6. Standard o.8oo 
* Each experilllent repreeent.1 an average of two determinations. 
** SFE: Standard tat •ulsion 
*** Nll"A : Non-esterified tatty aoide. 
G. THE RATE AT WHICH TRIGLYCERmBS ABE HIDBOL!ZED IN THE PREBml'CE OF 
CLEARING FACTOR 
To .)8.4 ml ot preheparin, ncrmal. pla811a containiDg 70,000 
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units ot cliaaolved clearing !actor, 9.6 Ill. ot ataldard tat emulsion are 
addeti and the mixture ie incubated at .37° c. in a water bath. At 0 time 
and atter 5, 10, 15, .)0 minut.es, l, 2, .3, 4, 5, &Id 6 hours ot incuba-
tion, 1.0 ml Ulllples ot the mixture are taken &Id the concentration ot 
non-esterified .tatt.y acids and g:cycerol are determined. In botil glycerol 
and non-esterified tat"cy acid determinations, duplicate ssples ot 1.0 
Ill are take. The decrease in optical density ot the mixture cilring tile 
above time intervals is also measured. Along with samples containing 
clearing !actor, a control consisting ot preheparin plasma and standard 
tat e&ll.sion are incubated and the concentration ot glycerol, non-ester-
ified tatty acids, as well as optical density 1 is determined at the 
time intervals given above. 
The results ot these det8l'lllinations are reported in 
Table XVI. and graphically presented in Figs. 7 and 8. 
T.A.BLE XVI. 
The Rate or Triglzceride Bzdrolysill 1n the 
Presence or c:Learing Factor 
I Incubation 
I Tilae crease lllin. X 
I 
0 ! 1.23 - 1.?2 0.6? -
2 \1.1,4 0.21 l.S2 o.s2 0.13 
10 1.61 0.38 lSh o.h2 0.23 
1$ 1.69 o.h6 1-$3 0.37 0.28 
30 1.8$ 0.62 1.6? 0.13 0.30 0.3? 
60 2.06 o.83 l.Bh 0.32 0.27 o.38 
90 2.18 0.9$ 1.2? o.h3 0.26 0.39 
120 2.26 1.02 2.02 o.so 0.26 0.39 
160 2.3$ 1.12 2.23 0.71 o.26 0.39 
2h0 2 • .39 1.16 2.37 o.es 0.30 0 • .3$ 
300 2.1,4 1.21 2.h7 0.9? 0.33 0.32 
I 360 2.46 1.23 2.h8 o.96 0.3? o.3o 
' 
, 
i Control/ 
lPlaaa 
.lfithout 
1 En•J!! 
0 1.22 l.SJ, o.66 
360 1.28 o.06 1.69 0.1$ o.6h 0.02 
Tile .tigures given represent an average of two detel'lllinations. 
* NEFA • N011-ester1tied fat~ acide. 
FICIJRE 7. 
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THE RATE OF TRIGLYCERIDE HYDROLYSIS IN 
THE PRESENCE OF CLEARING FACTOR 
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FI<IJRE 8. 
THE RATE OF TRIGLYCERIDE HYDROLYSIS IN 
THE PRESENCE OF CLEARING FACTOR 
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IV. COMPARISON OF '!HE LIP<LTI'IC ACTICH CF P.AHCREATIC LIPASE AND 
CLEARING FACTOR 
The lipo}¥tic action of pancreatic lipase and clearing factor 
on trigL;rcerides are ccaparlld in respect with: 
A. SUBSTRATE SPECIFICITY 
72. 
To the duplicate • aples containing 0.1 ag. pancreatic lipaae5 
dissolved in o.B al of veronal buffer of PH 8.6, 0.4 ml of 10 per cmt 
albuin solution md 0 • .3 Ill of standard fat •ulsion are added and tile 
llixture is incubated at .37° c. for .30 llirut. es in a water bath. The 
abOTe exper.!.Dient is repeated three tiaes, but instead of standard fat 
..W.sion, 0 • .3 Ill of o.B per cent triacetin, ch;r101111cra or beta lipopro-
teins are used respeotivel;r. After .30 lllinutes of incubation md at 0 
time, 1.0 al portion from each saapl.a is take and the concentration of 
non-esterified fatt:r acids is deterlllined. (The preparation of the l!llb-
strates used 1n this experiment is desorlbed on pages 6.3 to 6S). 
The above experiment is repeated and this time instead of 
pancreatic lipase .3 1000 units of clearing factar in each s•ple is used. 
(0.1 llli of pancreatic lipase on incubation with stsnd_.d fat euJsion 
present in preheparin, normal plaama gives aP}Z'oximatel:r the same de-
crease 1n optical densit:r as .31000 units of clesring factor.) 
The results o:f the above determinations are reported in 
Table xvn. 
S. Coauaercisl grade, obtained froa the WUson Laboratories, Division of 
WUson and Ccapan;r, Inc., CbiC8i01 nlinois. 
TABLE XVII 
COmparison of Lipolytic Action of Clearing Factor and 
Pancreatic Lipase on various Substrates 
I PA~FCREATIC LIPASE CLEARING 
Exp.l I 
' * :No. 1 Substrate Microequivalents of Titratable Acidity 
Change in 
!V'd.croequivalents of 
Ti tratable Acidi t.:i_ 
Microequivalents of 
Titratable Aci~ity_ 
J 0 min. 30 min. 0 min. I 30 min. 
1 Standard fat 1.60 
ellD.llsion 
2.305 o. 705 I o.883 
i 
! 
l ------ -,---- l -
. , ' I 3_l Triacetin ! 1.63 i 1.635 0.005 i 0.880 
' 
' ' 1 : 
3 i Chylomicrons 1.612 l 2.08 I 0.468 o.885 
1.277 
0.882 
1.466 
FACTOR I I 
_j 
changei_n __ i 
l"icroequivalents of l 
Titratable Acidit;y_ ! 
0.394 
o.oo2 
0.581 
4 r ~:ta-lipo- --1.83 1.98 lr 0.15 1.022 1.168 0.14~---
1 proteins 
' 
* Each experiment represents an average of two determinations. 
__, 
...._, 
• 
B. EFFECT OF PHOTAMINE llf THE ACTI<Il OF PANCREATIC LIPASE .AND 
CLEARING FACTOR 
74. 
Tile following systems are prepared in duplicate and incubated 
in a water bath at 37° c. !or 30 llinutes. 
(l) 1.2 Ill Teronal blt.t'er containing 0.1 mg./ml of pancreatic lipase + 
0.3 1111. standard !at emulsion. Tile pH o.t' the lllixture is 8.6. 
(2) Sue as above only 0.1111 o.t' normal plasma added. 
(3) s- as system (l) only 0.1 Ill plasma and 40 ag. of albumin are 
added. 
(4) 1.2 Ill naraal plaaa conta:l.n:l.ng 0.1 mg./Ill of pancreatic lipase + 
0.3 Ill standard !at ellllla ion. 
($) S81le as system (4) only 4.5 ag. prot1111ine are added. 
(6) 1.2 Ill naraal plalllll& containing 3,000 units clearing !actor + 
0.3 Ill standard !at •ul.sion. 
(7) Same as syst• (6) only 4.5 ag. protamine are added. 
(8) 1.2 Ill bo..t'i'er containing 3,000 \11lits clearing !actor + 0.3 ml 
standard !at tiiiUl.Bion. 
(9) 1.2 Ill nol'llal pla1111a (no 8llS1JIS) + 0.3 1111. standard tat eaulsion. 
At 0 lllinutes Ill d attar 30 a:l.nutes o.t' incubation 1.0 Ill aliquot 
!ran each s1111ple is taken end optical density and non-esterified tatty 
acid concentrations are detel'lllined. Tile results o.t' this determination 
are reported in Table XVIII. 
TABLE XVIII. 
The Effect ot Protallline and Sel'lllll Proteins on the Lipolytic Action ot P1111creatic Lipase 1111d Clearing Factor 
• Time ot Incubatioa 
Exp. Lipel.ytic Syatem Additione l5 •'"· )15 "'"· D. No. J.gent ODii *~ 6D WM Microequinlenta Acid *** 1. J!ancreatic Butter + SFE 
-
.so o.83 .76 .as 
LiEase E!! 8.6 
2. Pancreatic Butter + SFE 0.1 ml Plasma .62 0.911 .22 1.88 0.869 
LiE••• E!! 8.6 
3. Pancreatic Batter+ SFE O.llll Plaaa .71 0.916 .7 2.164 1.248 
Lil!!ae E!! 8.6 4o !I llbuain 
4. Pancreatic Plasma + .lSFE 
-
.65 1.60 .19 2.30!) 0.705 
Lipase 
s. Pancreatie Plamna + SFE Protamine .65 1.61 .38 2.23 0.620 
LiEase 4.5 !I 
6. Clearing Butter + SFE .68 .868 .67 0.870 
Factor EH 8.1 
~- --· 
7. Clearing Pluma + SFE - .68 1.65 .36 2.215 o.S65 
Factor 
8. Clearing PlaBma + SFE Protamine .65 1.63 .52 1.81 0.180 
Factor 4.5 lllg 
9. Control Plasma+ SFE - .64 1.54 .63 1.57 
No 8nSYJ11e 
• Each uperilllent repreaents en average ot tvo detemin&tions. iHIOD • Optical Density. *HSFE • Standard tat emal.aion. 
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RESULTS AND DISCUSSION 
Purification o! Clearing Factor. - The results o! attempted 
puritication ot heparin-induced clearing !actor by low temperature 
ethanol fractionation o! post.hepariD plaaaa are swomarized ill Tabla I. 
Considerable lipemia clearing activity is found ill Fraction I + III -
l, 2, 3 o! post.hepar:fn plasma. On further fractionation, however, the 
lipolytic activity is completely lost. It has not been established 
which steps are responsible !or the disappearance o! the lipallia clear-
ing activity. 
The clearing !actor vas aore successfully concentrated by the 
ether ext.raction aethod developed ill the course o! this study. By this 
method, OTer 90 per cant o! the original clearing activity is found in 
a semi-solid layer comprising approxiMately 2 per cent o! the original 
plasma volume. From this layer, the clearing !actor is then ext.racted 
into a glycine butter (tt crude clearing !actor preparation"). It has 
not been possible to demonstrate with this method the presence o! clear-
ing !actor in plasma or serum o! normal untreated individuals. 
The residue o! the layer attar extraction o! the clearing !actor 
is a white tibrous material. This material is insoluble in dilute acids 
or alkali. Since the addition o! huaan !ibrinolyein6 resulted in partial 
solubilization o! the residue, it is preSUIIIed that at least part ot the 
l&J&r (containing the clearing !actor) consists o! fibrin. 
6. Courtesy of Dr. Eugene c. Looais, Parke, Davis and Co., Detroit, Mich. 
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The crude clearing factor preparation still contains IUlly iJIIpur-
ities, eraong them fibrinogen and. prothrombin. When the crude clearing 
factor preparation is incubated. with siJIIplastin 1 clot formation is tek-
ing place. 
The association of clearing factor with prothranbin and. fibrinogen i 
is not limited. to the ether ext.raction IISthocl.. All 1118 thocl.s used. tor the 
separation of clearing factor (i.e., low temperature ethanol fractiona-
tion (16), precipitation at pH 5.6 (95), adsorption on bariwn sulfate 
or calciUIII phosphate columns (96) result in preparations containing fibrin-
ogen encl. prothrombin. 
The results of attanptecl. purification of the crude clearing factor 
preparation by precipitation ~th a.moniwn sulfate, by fractionation at 
various pH levels or by adsorption on calcillll phosphate gel, are present-
eel. in Tabl11s III, IV and. V. 
On precipitation of the crude clearing factor preparation with 
RllmoniUIII sulfate, the highest lipolytic activity, as Jlleasurecl. by glycerol 
evolutian, is found. in the tractions obtained. at .30 and. 40 per cent sat-
uretion. Considerable activity, however, is scattered through the other 
tractions. After cl.ielysis, the lipolytic activity of the tractions is 
lost even when the preparation is cl.issolved in preheparin plaaa. Optical 
density aeasurements could. not be evaluated since it has been noted. that 
0,1 M (NH4)2S04 solution alone causes optical clearing of a tat emulsion. 
This 11 spontaneous" clearing phenomenon is not acc011paniecl. by evolution 
* 1. Obtained. from Waruer-Chilcott Laboratories, Morris Plains, N.Y. 
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of glycerol and is d.le to decreasing the stability of the emulsion. 
Fractionatim of the cruds clearing !actor preparation by 
changes in hydrogen ion concentration produced only negligible puri-
fication. Clearing activity waa scattered aong the various fractions 
(pH 510; 5.5; 6.0; 6.5; 6.8) and contained approJdJIIately the s•e illt-
purities as the starting material. 
Adsorption on clearing !actor preparation vi th calcium phosphate 
gel did not result in further purUicatiCIIlo By adsorption methods, 
Nikldla (96) obtained up to 40-f'old puri!ication of' clearing factor 
using postheparin plasma as starting material. But the crude clearing 
!actor preparation used in this study, already, is at least as pure as 
the material which Nikkila obtained by his purification method. It h 
quantitatively adsorbed on calciua phosphate gel and also quantitative-
ly eluted with sodium citrate. It tharatora appears that the impurities 
which Nikldla removed by adsorption on calcium phosphate gel have al-
ready been removed by the early steps in our ether extraction method. 
Mora than 50 per cent puri!ication of' the cruds clearing factor 
preparation was achieved by repeated extractions with ether (Tables VI 
and vn) . The final preparation of' clearing !actor ("purified clearing 
factor preparation•) contained leas than a one-hundred-and-thirtieth 
(l/130) part of the protein present in the etartiag material and re-
tained more than 50 per cent of' the total original lipolytic activity. 
Physico-chemical Characteristics of' Purified Clearing Factor 
8 
Preparation. - Heating at 60° C. !or 15 minutes or incubatim with trypsin 
8. Obtained f'rom Nutritional Biochemicals COrp., Cleveland, Chio. 
for 6 hours at 37° c. c011pletely destroys the lipolytic activity of 
the purified clearing factor preparation. These findings indicate that 
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protein is an essential part of clearing factor. They are in agreement 
with the observation that clearing activity in intact postheparin plasma 
is similarly destroyed b;y beat end trypsin. 
Stability tests of clearing factor show (Table VIII) that the 
0 purified clearing factor preparation, when kept in a dry form at 25 C. 
for 7 da;ya, suffers no loss of activity. In veronal buffer solution, 
however, at 0° c. after 7 days, only 50 per cant of the original activity 
is retained. Addition of albumin to the clearing factor solution in-
creases its stability only slightly. 
Analtical ultracentrifugation and free-boandar,y electrophoresis 
of the purified clearing factor preparation show one major and two minor 
components (Figs. l and 2). Attempts to detemine which of the ultra-
centrifugally separated c0111ponent. is responsible for lipolytic activity 
of clearing factor have not been successful. 
Since the ultracentrifugal and electrophoretic studies indicate 
that the purified clearing factor preparation still contains considera-
ble impurities, chemical analytical studies of this preparation have been 
limited to the determination of protein, lipids and pol;yaaccharides. The 
purified clearing factor preparation consists mainly of protein and is 
free of lipids. On testing for tbe presence of glycoprotein& b;y staining, 
negative results were also obtained. However, the staining method for 
the dete:nnination of glycoprotein& aaployed here is not sensitive enough 
to disclose dilate concentrations ot glycoprotein. 
so. 
Kinetic Studies on Purified Clearing Factor. - In studying the 
effects of temperature on the initial rate of the reactions (Table IX) 
it was found that the optimal temperature for clearing factor activity 
is in the range between 37° and 40° c. On substituting the values of 
clearing factor activity at various temperatures into the Arrhenius 
equation 
E (1' ln K = -R "T)+-constant 
and plotting it against x andy coordinates, a straight line is obtained. 
From the slope of the line (Fig •. 3) the activation energy E for clearing 
factor is calculated and found to be approximately 10,000 cal. 
'Ihe study of the reaction velocity of clearing factor over pH 
ranges from 5.0 - 9.0 is summarized in Table X and is graphically pre-
sented in Fig. 4. The hydrogen ion concentration for optimal clearing 
factor activity is found to be in the range of pH 7.9 - 8.1. 
The velocity of the clearing reaction is found to increase as 
the concentration of cle'l.ring factor increases (:!'able XI and Fig. 5). 
A linear relation between the rate of reaction and the concentration 
of enzyme is present at lower concentrations of clearing factor. 
Increase in the concentration of substrate is accompanied by 
increase in the velocity of the reaction catalyzed by clearing factor 
when other factors are kept constant and the concentration of the 
substrate is low (Tables XII and XIII and Fig. 6). The method of 
Lineweaver and Burlc (83) has been used to determine !0-chaelis-Nenten 
constant 
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o! clearing !actor. en substituting the Talues o! clearing !actor 
activity found at di!!erent substrate concentration levels into the 
Michaelis-Menten equation 
l.b(l)+l i r s v 
and plotting it against x and y coordinates a straight line is obtained. 
From the slope or the line the Miobaelis constant Km is calculated and 
is found to be 0.21 M. 
study or the rate or trigcyceride hydrolysis in the presence or 
clearing !actor discloses that during the earl7 stage o! the reaction 
the production o! non-esterified tatty acids ia linear with the increase 
in the reaction time. Thus the initial stage or the clearing reaction 
is or sero order. The rate or the clearing reaction vas detel'lllined b7 
measuring the end products or trigl708rids hydrol711is and change in 
optical density. Table XVI and Figs. 7 and 8 indicate that the non-
esterified tatty acid concantration sharply rises during the first 
60 minutes o! the reaction and continues to rise slightly during the 
next tiva hours. The rate ot change in optical density during the first 
60 minutes runs naarl7 parallel to the rate ot liberation ot non-aster-
if1 ed tatty acids. en the other hand, the decrease in optical density 
stops attar one hour and attar 3 hours the optical density begins to 
increase again. rn contrast to the initial increase in non-esterified 
tatty acids, the concentration o! glycerol does not begin to rise until 
30 minutes atter initiation o! lipol7$is. The concentration o! gl7cerol 
increases gradually and is tound to be highest attar 5 hours or incubation. 
82. 
It is suggested tl4) that the delayed increase in glycerol con-
centration during 1he clearing reaction is due to the selective action 
of clearing factor on the alpha and beta positions of the trigl;roeride 
ester bonds. Such selective action of clearing factor would produce 
first non-esterified fatty acids and aono and di-glycerides before free 
glycerol is released. Glycerol estimation is based on the formaldehyde 
formed b,y the oxidation of either glycerol or monoglycerida with period-
ate. There is no evidence that the digl;rcerides take part in this re-
action. Therefore, the glycerol determination would reflect only more 
advanced stages of lipolysis in the reaction& catalyzed by clearing 
factor. 
It vas found that clearing factor hydrolyses the atandard fat 
•ulsion and hWRan chylomicra at about the same rate, while it did not 
degrade triacetin. The fact that triacetin is not hydrolyzed b,y clear-
ing factor elildnates the possibility that clearing factor is similsr to 
or identical with ali-esterase& of blood. 
Incubation of purified clsaring factor preparation vi th beta 
lipoproteins (density 1.04 g/cc) also results in an increase in non• 
esterified fatty acids (Table XIV). Since this lipoprotein prepara-
tion usually contains some ohylomicra, it vas not established whether 
the released non-esterified fatty acids originated from the chylomicra, 
the beta lipoproteins or from both. 
When the purified clearing factor preparation is dissolved in a 
buffer and is miXed with standard tat emulsion, no clearing takss place 
until at least a aall aount of plasma or albuain is added to the miX-
ture (Table IV). Addition of calciua ions partiall;r replaces the re-
quirement for protein. It therefore appears likely that the f1mction 
83. 
of the protein is to accept the fatty acids formed auring the clearing 
reaction. 
Korm (63, 65) reports that lipoprotein lipase hydrolyzes tri-
glycerides only if they are i~ complex with protein. Gn the other hand, 
our observation indicates that the reaction catalyzed by clearing factor 
can proceed without added proteins provided calcium ions are present. 
This seems to imply that tissue lipoprotein lipase and heparin-induced 
plasma clearing factor are not identical. 
Pancreatic lipase and clearing factor acted alike in respect to 
substrate specificity or protein requirement (Tables XVII and XVIII). 
Eowever, the effects of many other factors (i.e., various inhibitors) 
on these two lipolytic agents have not oeen studied in this work. 
Therefore, it is not warranted to conclude that pancreatic lipase and 
clearing factor are identical. On the other hand, since both pancreat-
ic lipase a:1d the heparin-induced clearing factor require protein, a 
distinction of these two lipolytic agents on the basis of protein re-
quirement, is not possible. 
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SUMMARY AND CONCLUSIONS 
In order to stu~ the lipolytic action and the kinetics of hepar-
in-induced lipemia clearing !actor, isolation and purification of this 
factor from hmnan postheparin pl&BIIa has been undertaken. By a newly 
developed method consisting of repeated extractions or postheparin plasaa 
with an ether-ethmol aixture, a 130-fold purification (based on protein 
content) ot clearing factor has been obtained. The purified clearing fac-
tor preparation contains approximately 50 per cent of the total or~inal 
activity. No clearing factor is found in the plama or serum of no:nnal 
untreated individuals when tested by the above method. 
Analytical' ultracentrifugation and free boundary electrophoresis 
of the purified clearing factor preparation shows one major and two minor 
components. Attempts to e1tablish which of these ultracctrii'ugally sep-
arated component (-s) is re1ponaible tor clearing factor activity failed 
because of the instability of the puri.f'ied clearing !actor preparation in 
aqueous solutions. 
Purified clearing !actor preparatiob consists mainly of protein 
and is free of lipids. Heating of the purified clearing factor prepara-
tion for 15 minutes at 60° C. or incubation with trypsin for 6 hours at 
37° c. completely destroys its activity. On the basis of these findings 
and fr0111 the results of kinetic studies, it is concluded that clearing 
factor is an enzyme catalyzing the hydrolysis of triglycerides. 
Activity of clearing factor is optimal at temperatures between 
37° c. - 40° c. and at hydrogen ion concentrations between pH 7.9 and 8.1. 
The activation temperature o£ clearing £actor is approximately 101 000 cal. 
as. 
and the Michaelis constant Kill is 0.21 K. Clearing factor catalyzes the 
hydrol;yais of trigly'Ceridea present in coconut oil anulaion or in human 
chylomicra at about the same rate. It does not hfdrolyze triacetin. On 
this basis the possibility can be excluded that clearing factor is identi-
cal with alli-esterasea of blood. 
The initial stage of the reaction catalyzed by clearing factor 
proceeds at a rate of sero order. During the first 30 minutes of the re-
action, the production of non-esteri.f'ied fatty acids is about six timea 
greater than the production of glycerol. This agrees with the reports 
that clearlng factor acta selectively on the alpha and beta bonds of 
triglycerides. 
In a s;yatan containing coconut oil eaulsion at least Slllall amounts 
of protein are required for the lipolytic action of clearing factor to take 
place. Since addition of calcium ions to the syste replaced the require-
ment of protein, it seems that the function of the added protein is accept-
ance of fatty acids formed during the clearing reaction. 
Clearing !actor and pancreatic lipase act alike in respect to 
nbstrate specificity and protein requirmmt. Since the effects of the 
other factors on clearing factor and pancreatic lipase have not been stud-
ied, no conclusion can be drawn whether or not these two lipolytic agents 
are identical. 
These studies indicate that the heparin-induced clearing factor in 
plasma is closely related to the lipases present in other biological fiuids 
and tissues. However, a full invssti~tion of the relationships of the 
lipases requires purified preparations of such lipases from various sources. 
The purification of these lipases is beyond the scope of this study. 
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ILLUSTRATION 
Semi-solid Layer Between Aqueous and Ether Phases after Centrifugation 
of Plasma-Ether Mixture. 
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After the intravanoue administration of heparin to aniJIIals or 
hUIIlllll subjects, an enzyme, the lipaaia clearing .!actor, appears in the 
blood. As a result of the action or this heparin-induced clearing !actor, 
neutral tat present in lipud.c plaaa is hydrolyzed into fatty acids and 
glycerol, llhile at the eame ti.llle the turbidity of the lipemia pl&llllla is 
decreased. 
In order to study the kinetice of this lipolytic action or clear-
ing factor, the separation and purification of the clearing factor !rom 
postheparin hwnan pliUillla has been carried out by a method developed in thie 
* etud:y in the following mannert Postheparin hUlllan plasma is mixed in equal 
parts with a solution consisting of 2 parts ethanol and l part ether at -5° c. 
Upon incubation of this mixture at -~ c., numerous particles of low specific 
density appear in the mixture. On centrifugation, these particles form an 
interphase of semi-solid consistency between the aqueous and the ether phase. 
Ninety per cent of the total activity originally present in the 
postheparin plaSIII& are recovered llhen the semi-solid layer is suspended in 
pla11111a cL normal non-heparinized subjecte. Suspension of this eeai-solid 
lqer in veronal buffer of pH 8,1 and repeated extractions with ethyl ether 
result in further purification of the clearing factor preparation, The 
.tinal purified preparation of clearing factor represent• a 130-!old purifi-
cation (based on protein content) and contains approximately 50 per cent 
* PosthGarin pl&Bill& is plaaa collected from normal fasting individuals 
30 iiau es iiter injection of 2 ag/kg body weignt of heparin. 
2. 
of the total original aotinty. Attaapts to dl!llllonstrate the presence of 
clearing actin ty in the plaama or aerwa of normal fasting indi"Yiduals by 
this extraction method have not been successful. 
The lipolytic activity of clearing fact.or is measured in a syst• 
* consisting of standard fat 8111ulsion and the purified clearing factor prepoo 
aration which is dissolved either in preheparin plasma or in 3.3 per cent 
albumin solution. The ll8asurements consist in determinations of the de-
crease in optical density and the increase in concentration of nonester-
ified fatty acids or glycerol. 
Ultracentrifugal and electrophoretic analyses of the purified 
clearing factor preparation show one major and two minor components. 
Attempts to determine which of the three c0111ponents obtained by ultracentrifug-
al separation llight be responsible tor the lipolytic action of clearing factor 
have not been suocessful because of the instability of the purified clearing 
factor preparation in aqueous solutions. 
On chemical analysis the purified clearing factor preparation con-
sists mainly of proteins and is free of lipids. Glycoprotein has not been 
demonstrated in this preparation by the staining method. 
The purified clearing factor pl"eparation exerts its optimal activ-
ity at temperatures between 37° and 40° c. and at hydrogen ion concentrations 
* Standard tat •ulsion was generously supplied by Dr. E.A.Havk, Medical 
DiVision, Dept. of Clinical Investigation, The Upjohn Company, Kalamazoo, 
Michigan. It consisted ota 15% coconut oil dispersed as one micron particles 
in water containing 0.5% Pluronic (a nonionic detergent) and l.o% polyglycer-
ololeate. 
3. 
between pH 7.9 and 8.1. Applying the Arrhenius equation 
-E (1~ ln K: !r r;+-constant 
to the clearing factor activity values obtained at various temperatures, 
the activation temperature of clearing factor is calculated to be 10,000 cal. 
A linear relationship exists between concentration of clearing factor 
and its lipolytic activity in the range of dilute concentrations (from 0.5 
to 1.0 mg. of protein). In a range of dilute concentration of substrate 
the velocity of the reijc tion catalyzed by clearing factor increases when 
the concentration of triglycerides increases. Applying the ¥~ch~elis 
equation 
1 Km(l\ 1 v= v s)+;; 
to the clearing factor activity values obt~ined at different substrate 
levels, the Michaelis constant (Km) of clearing factor is calculated to 
be o. 21 !1. 
Clearing factor hydrolyzes the triglycerides present in a coconut 
oil emulsion and in human chylOIIii..ct'a at about the same rate, omile it 
does not hydrolyze triacetin. In the case of coconut oil emulsion, no 
hydrolysis takes place until a small amount of protein is added to the 
system. Since the protein can be replaced by tre addition of calcium 
ions, it appears that the function of the protein is to accept the free 
fatty acids formed during the clearing reaction. 
4. 
Tbe rate of the reaction catalYBed by clearing factor has been 
studied by determining the evolution of nonesterified fatty acids and glycer-
ol and by measuring changes in optical density. During the first 10 minutes 
ot the reaction, the rate of increase in the concentration of nonesteritied 
fatty acids as well as the decrease in optical density follow the curve of 
zero order reaction. No increase in concentration of ~carol is found un-
til the reaction has proceeded for about 30 minutes. 
This delay in the evolution of glycerol is in agreement with the 
reports that clearing factor primaril.7 hydrol111es triglyceride bonds in al-
pha and beta positions. The tact that the method employed for the determin-
ation of glycerol does not detect the diglycerides formed first during the 
reaction, but only monoglycerides and glycerol, explains the delayed evolu-
tion of glycerol. 
Pancreatic lipase and clearing factor act alike in respect to 
substrate specificity and requirements for protein. Since no other compar-
isons have been carried out, no conclusion can be drawn as to the actual 
identity of these two lipolytic agents. 
In 8WIIIII&ry1 the analytical and kinetic studies on the purified 
clearing factor preparation show that heparin-induced clearing factor is a 
lipolytic enz;yme which catal111es the hydrolysis of triglyceride&. Further 
investigations are required to determine the exact relationship between 
clearing factor and the lipues present in other biological fluids and 
tissues. 
CURRICULUM VITAE 
BRONIUS BASKYS 
Born January 7, 1920, Siauliai, Lithuania. 
Parents: 
1944 
1945-1949 
1949 
1952-1954 
1955 
1956-1959 
1957-
1957-
1959-
Joseph and Barbara Baalcye, engaged in agri.culture. 
Jurbarkall State Gymnaai11111, Diploma 
Hamburg University, Medicine 
Entered u.s.A. 
Northeastern Uninrsity, night courses in chEmistry 
A.M. in BiochEIIIistry, Boston University 
Candidate for degree o£ Doctor o£ Philosophy, Boston University 
Research Fellow in Dermatology, Harvard Medical School 
Researfh Fellow in Dermatology, Massachusetts General Hospital 
Public Health Service Predoctoral Research Fellow 
PUBLICATIONS 
l. Le'VW, W.F., and Baskys, B.: Effects o£ intravenous administration 
o£ £at emulsions and their emulsii'ying agents. I. Effects on clearing 
factor activity, electrophoretic pattern and clotting time o£ blood o£ 
dogs. J. Invest. Dermat., 28:317-320, 1957. 
2. Boyd, w.c. and Baskys, B.: Pre- and postreaction pH of two specifically 
interacting large-11olecule systems. E:xperientia, !J:328, 1957. 
3. Bask:ys, B., Lever, W.F., and nein, E.: Separation o£ heparin-induced 
lipemia clearing £actor from h11111&n plasma. Fed. Proc., 17:11, 1958. 

